LECTURES AND PRESENTATIONS:
“Psychiatry in the 1990’s” – American Psychiatric Association, Albany Chapter 1985
Instructor, Resident’s Survival Lecture Series, Albany Medical Center
Hospital 1985-1987
Coordinator and Founder, Special Lecture Series in Psychiatry,
Albany Medical Center Hospital, Albany, N.Y. 1986
“Induced Convulsions-Therapy or Quackery?” Grand Rounds Lecturer,
Albany Medical Center Hospital 1986
“Orgasm of Death-Autoerotic Asphyxia and the Psychological Autopsy.” Grand
Rounds Lecturer, Albany Medical Center Hospital 1987
“Forensic Psychiatry and the Role of the Court Clinic” Lecture to New York State
Committee on Probation Activities, Syracuse, New York 1987
“Competency to Stand Trial and Criminal Responsibility” Lecture to Advanced
Criminal Procedure Course, Syracuse University School of Law, Syracuse, N.Y. 1988
“Orgasm of Death-Autoerotic Asphyxia and the Psychological Autopsy,”
Central New York Psychiatric Center, Marcy, N.Y. 1988
“Neonaticide: Population Control, Late Abortion or Murder?” Central New York
Psychiatric Center, Marcy, N.Y. 1988
“AIDS and the Law: Forensic Psychiatric Issues,” Westfield Area Community
Mental Health Center, Westfield, M.A. 1988
“Convulsive Therapy; The Next Decade,” University of Massachusetts Medical
Center Residents Lecture 1988
“Families, Murder, and Insanity”, American Academy of Forensic Sciences
Annual Meeting, Las Vegas, Nevada 1989
“Negligent Release of a Suicidal Person,” Center for Adults and Families,
Westfield, Massachusetts 1989
“The Roger’s Decision and the Right to Refuse Treatment,” Western
Massachusetts Hospital, Westfield, Massachusetts 1989
“Neonaticide: Population Control, Late Abortion or Murder?” Duke University,
Grand Rounds Lecture. Durham, North Carolina 1989
“Infanticide: Dealing with Parents Who Kill” Grand Rounds Lecture, John
Umstead Hospital, Durham, North Carolina 1989
“Tort Liability in Involuntary Civil Commitments,” Westfield Area Mental Health
Center, Westfield, Massachusetts 1989
“The History and Current Status of the Right to Refuse Treatment,” Westfield
Area Mental Health Center, Westfield, Massachusetts 1989
“Malingered Mental Illness: Case Law in the Nineteenth Century.” University of
Massachusetts Medical Center. 198
“What’s Up Doc?: Forensic Sciences in the 21st Century.” Panel Moderator,
American Academy of Psychiatry and the Law Annual Meeting, Washington, D.C. 1989
“Negligent Release,” Grand Rounds Lecture, Worcester State Hospital. 1990
Moderator: “Current Developments in Forensic Psychiatry,” American Academy
of Forensic Sciences Annual Meeting. 1990
Moderator: “The Relationship Between the Court and the Doctor on the issue
of an Inpatient’s Refusal of Psychotropic Medication,” American Academy of
Forensic Sciences, Annual Meeting 1990
“Scared to Death.” Forensic Conference, University of Massachusetts Medical
Center. Worcester, Massachusetts 1990
“Mental Status Examinations: A Forgotten Art.” Westfield Area Community
Mental Health Center, Westfield, Massachusetts 1990
“Antipsychotics in a Medical Setting.” Medical Center of Delaware 1990
“Antidepressants in a Medical Setting.” Medical Center of Delaware 1990
“Psychotic Disorders” A Four Lecture Series,” Medical Center of Delaware 1990
“Clozaril, Schizophrenia and the 1990’s,” Medical Center of Delaware 1990
“Worker’s Compensation Evaluations,” Medical Center of Delaware 1990
“Alcohol Drips in the Management of Alcohol Related Trauma.” Medical Center
of Delaware 1991
“Forensic Issues in the Conduct of Psychotherapy.” Delaware Academy of
Medicine, Wilmington, Delaware 1991
“Rescinding Commitments-Delaware Law and Practice.” Grand Rounds Lecture,
Medical Center of Delaware, Wilmington, Delaware 1991
“Ethics in the Practice of Forensic Psychology.” Widener University Institute for
Graduate Clinical Studies in Psychology, Chester, Pennsylvania 1991
“Women, Are You Prepared to Become Widows?” Wilmington, Delaware 1991
“The Great Impostors: Psychiatric Illness in a Medical Setting.” Grand Rounds,
Medical Center of Delaware, Wilmington, Delaware 1991
“Psychiatric Problems in Pregnant Patients: Prescriptions and Psychotherapy.”
Medical Center of Delaware 1991
“Case Conference on Schizoaffective Disorder.” Medical Center of Delaware 1991
“The Psychiatrists Responsibility for his Patient’s Driving.” American Academy
of Psychiatry and the Law, Orlando, Florida 1991
“Guilty but Mentally Ill and the Death Sentence.” American Academy of
Psychiatry and the Law. Orlando, Florida. 1991
“Responding to Death and Loss in the Workplace.” Medical Center of Delaware 1991
“Fentanyl and Midazolam in the Pediatric Intensive Care Unit.” Medical Center
of Delaware, Pediatrics Journal Club 1991
“Identification and Management of Schizophrenia in the Geriatric Population.”
Delaware Department of Health and Human Services, Division of Aging,
Wilmington, Delaware 1991
“Schizophrenia in the 1990’s: New Drugs, New Thinking.” Medical Center of
Delaware, Delaware Art Museum, Wilmington, Delaware 1991
“Autoerotic Asphyxia and The Psychological Autopsy.” Medical Center of
Delaware, Grand Rounds. 1991
“The Insanity Defense-Delaware Does it Differently.” Rotary Club,
Wilmington, Delaware 1992
“Conversion Disorder in the Medical Setting.” Medical Center of Delaware,
Department of Family Practice 1992
“Sexual Trauma for the Trauma Surgeon.” Medical Center of Delaware,
Wilmington, Delaware 1992
“Closed Head Injury-Understanding the Un-understandable.” Lecture for
attorneys and insurance claims representatives 1992
“Hopelessness in the 90’s.” Widener University 1992
“Expert Witness Demonstration and Practice,” Intensive Trial Advocacy
Program, Widener University Law School, Wilmington, Delaware 1992
“Refractory Schizophrenia, New Approaches” Coatesville Veterans
Administration Hospital, Coatesville, Pennsylvania 1992
“Psychotic Disorders: An Introduction and Emergency Treatment,” Delaware
State Hospital Residents Orientation Course 1992
“Workers Compensation: Issues for the 90’s.” Rotary Club of Newark, Delaware 1992
“Psychopharmacology and the Law” American Academy of Psychiatry and
the Law, Boston, Massachusetts 1992
“Review by Peers in Forensic Psychiatry” American Academy of Psychiatry
and the Law, Boston, Massachusetts. 1992
“Head Injury-Identification, Management and Outcomes.” Family Practice
Lecture, Medical Center of Delaware, Wilmington, Delaware 1992
“Personality Disorders” Alliance for the Mentally Ill Statewide Conference,
Wilmington, Delaware 1992
“Community Integration verses Separation/Protection.” Delaware Head Injury
Foundation, Wilmington, Delaware 1992
“Coping with Depression During the Holidays.” Delaware Commission for
Women and Women and Wellness Foundation, Wilmington, Delaware 1992
“Rapid Cycling Bipolar Disorder and Cyclothymia.” New Directions,
Wilmington, Delaware 1993
“An Overview of Anxiety Disorders and their Treatment.” Maryland State
Hospital at Crownsville 1993
“Statistics for Everyone.” American Academy of Forensic Sciences, Boston,
Massachusetts 1993
“Silicone Breast Implants-Psychic Stress Damages and Product Liability.”
American Academy of Forensic Sciences, Boston, Massachusetts 1993
“Scared to Death.” American Academy of Forensic Sciences, Boston, Massachusetts 1993
“Zombie Sex Slaves-Serial Sexual Homicide-A Motivational Model.” American
Academy of Forensic Sciences, Boston, Massachusetts 1993
“Evaluation of Head Injured Persons.” Traveler’s Insurance Company, Vienna, Virginia 1993
“Geriatric Depression.” Lecture to community physicians in Chestertown, Maryland 1993
“Competency, Criminal Responsibility and Dangerousness.” Maryland State
Hospital at Crownsville 1993
“Head Injuries-They’re Not All the Same.” Delaware Head Injury Foundation
Symposium, Wilmington, Delaware 1993
“Head Injury: A New Conceptual Model for Understanding Traumatic Brain
Injury.” Delaware Head Injury Foundation Symposium, Wilmington, Delaware 1993
“Medicine in the 21st Century.” Mensa Colloquium. Philadelphia, Pennsylvania 1993
“Battered Women Syndrome.” Widener University School of Law 1994
“Picking the Right Doctor.” Medical Center of Delaware, Wilmington, Delaware 1994
“Third Generation Anti-Depressants-What’s New and What’s Coming.”
Wilmington, Delaware 1994
“Psychiatry in the Workplace: The Evaluation of Stress.” American College of
Occupational Medicine, Delaware Chapter, Wilmington, Delaware 1994
“A Review of the New Psychoactive Drugs.” Medical Center of Delaware,
Grand Rounds, Wilmington, Delaware 1994
“Psychoactive Medications for the 21st Century.” Wilmington, Delaware 1994
“Ethics and Managed Care-Whose Decision Is It Anyway?” Psychiatric Society
of Delaware, Wilmington, Delaware 1994
“Traumatic Brain Injuries: Medication Approaches and Long Term Outcomes.”
Delaware Head Injury Foundation. Wilmington, Delaware 1995
“Attention Deficit Disorder v. Bipolar Disorder: How to Differentiate between
the Two Diagnoses.” New Directions, Wilmington, Delaware 1995
“Seasonal Affective Disorder.” Zeneca, Wilmington, Delaware 1995
“Forensic Psychiatry in Criminal Investigation.” The Smithsonian Institute,
Washington, D.C. 1995
“Treatment of Depression – The New Psychopharmacology.” Riverside Hospital,
Wilmington, Delaware 1995
“The Assessment of Neuropsychiatric Conditions.” Delaware Head Injury
Foundation, Wilmington, Delaware 1995
“Mental Retardation: An Overview.” American Academy of Psychiatry and the
Law, Seattle, Washington. 1995
“Developmental Disabilities and the Death Sentence.” American Academy of
Psychiatry and the Law, Seattle, Washington 1995
“Focus on Depression: From Observation to Outcome.” Grand Rounds Lecture,
Riddle Memorial Hospital, Pennsylvania 1995
“Attention Deficit Disorder, Bipolar Disorder, Depression, Anxiety and Head
Injury: What’s the Difference.” New Directions, Wilmington, Delaware 1996
“Depression in Primary Care Settings.” Wilmington, Delaware 1996
“Self Injurious Behavior.” Fort Washington, Pennsylvania 1996
“Management of Depression and Anxiety for Family Practitioners.” Wilmington, Delaware 1996
“Differential Diagnosis and Co-Morbidity in Attention Deficit Disorder.”
CHADD Newark Chapter, Newark, Delaware 1996
“Psychotropic Medication, Substance Abuse, and Crime.” University of
Delaware, Wilmington, Delaware 1996
“Self Injurious Behavior.” Crozier Chester Hospital, Chester, Pennsylvania 1996
“Threat Assessment.” E.I. DuPont de Nemours, Wilmington, Delaware 1996
“Managed Care, Medication, & Malpractice on the Horizon.” American Academy
of Psychiatry and the Law, Puerto Rico 1996
Moderator – “Stalkers, Violence, and the Insanity Defense.” American Academy
of Psychiatry and the Law, Puerto Rico 1996
“Prediction and Management of Violence in the Workplace.” Occupational and
Health Physicians of Delaware, Wilmington, Delaware 1996
“Mental Health and Substance Abuse: Separate or Related Entities” University of
Delaware, Wilmington, Delaware 1997
“Psychotic Disorders and Novel Antipsychotic Medications.” Delaware State
Hospital, Wilmington, Delaware 1997
“An Overview of the Insanity Defense.” Rotary Club of Hockessin, Delaware 1997
“Psychiatrist v. Psychologist.” Brain Injury Association of Delaware 1997
“Psychoses.” Christiana Care Health Systems, Department of Family Practice,
Resident Teaching Program 1997
“Eating Disorders.” Wilmington, Delaware 1997
“Confidentiality, Competency, Dangerousness and Managed Care: An Overview of
Forensic Psychiatry.” Southern New Jersey Psychiatric Association. Philadelphia,
Pennsylvania 1997
“The Unstable Employee: How to Balance Your Legal, Ethical, and Co-Worker
Obligations with Confidence.” Wilmington, Delaware 1997
“Psychiatry for the Non-Psychiatrist.” Delaware Academy of Medicine. Wilmington,
Delaware 1998
“An Overview of Affective Disorders.” New Directions. Wilmington, Delaware 1998
“Interviewing Children with Attention Deficit Disorder.” Children’s Advocacy Center,
Wilmington, Delaware 1998
“Neonaticide, Late Abortion and Murder.” Keynote Address to the Annual Meeting of
the New Jersey Psychiatric Association, New Brunswick, New Jersey 1998
“The Biology and Psychopharmacology of Mental Illness.” Wilmington College,
Wilmington, Delaware 1998
“Issues in Forensic Psychiatry.” Grand Rounds Lecture at Cooper Medical Center,
Camden, New Jersey 1988
“Sexual Abuse Reporting.” Christiana Care Health Systems. Wilmington, Delaware 1998
“Review of Antidepressants.” Department of Family Medicine, Christiana Health Care
Services, Wilmington, Delaware 1998
“Psychopharmacology for Master’s Level Therapists.” Wilmington College, Wilmington,
Delaware 1998
“Depression and Sexual Dysfunction.” Manayunk, Pennsylvania 1998
“Depression Update.” Philadelphia, Pennsylvania 1998
“Depression and Sexual Dysfunction.” Philadelphia, Pennsylvania 1998
“Mental Injuries in the Next Millennium.” Defense Counsel of Delaware, Wilmington,
Delaware 1998
“Treatment of Sexual Aggression.” Annual Meeting of the American Academy of
Psychiatry and the Law, New Orleans, Louisiana 1998
“Moderator, Mental Health Update, Focus on Women.” Medical Society of Delaware,
Wilmington, Delaware 1998
“Depression and Sexual Dysfunction.” V.A. Medical Center, Cotesville, Pennsylvania 1998
“Understanding and Treating Anxiety Disorders for the Primary Care Physician.” North
Penn Hospital, Landsdale, Pennsylvania 1998
“Depression and Sexual Dysfunction.” Red Bank, New Jersey 1998
“A Forensic Sampler: Part 1” University of Pennsylvania Department of Psychiatry,
Philadelphia, Pennsylvania 1999
“Depression and Sexual Dysfunction.” Pfizer. Dilworthtown, Pennsylvania 1999
“Depression and Sexual Dysfunction.” Medical Grand Rounds, Paoli Memorial
Hospital, Paoli, Pennsylvania 1999
“Psychopharmacology of Aggression.” Grand Rounds, Clifton T. Perkins Hospital,
Columbia, Maryland 1999
“Depression: What’s Sex Got to do with It?” Grand Rounds, Holy Redeemer Hospital,
Meadowbrook, Pennsylvania 1999
“Depression: What’s Sex Got to do with It?” Bryn Mawr, Pennsylvania. 1999
“Depression: What’s Sex Got to do with It?” Grand Rounds, Penn Foundation for
Behavioral Health, Langhorne, Pennsylvania 1999
“A Forensic Sampler: Part 2.” University of Pennsylvania, Philadelphia, Pennsylvania. 1999
“Depression: What’s Sex Got to do with It?” Philadelphia, Pennsylvania 1999
“Atypical Antipsychotics: An Overview.” Grand Rounds, Sinai Health Systems,
Baltimore, Maryland 1999
“Atypical Antipsychotics and Tardive Dyskinesia.” Grand Rounds. Perry Point, VA
Hospital, Perry Point, Maryland 1999
“Alcohol and Substance Abuse.” Justices of the Peace, State of Delaware, Annual
Conference, Dewey Beach, Delaware 1999
“Roundtable Discussion on Psychiatry.” Philadelphia, Pennsylvania 1999
“Alcohol and Substance Abuse: A New Policy:” Superior Court Judges, State of
Delaware, Annual Conference, Lewes, Delaware 1999
“Women and Mood Disorders.” Dilworthtown, Pennsylvania 1999
“Psychotropic Drugs for the Family Practitioner.” Christiana Care Health Services,
Department of Family Practice 1999
“Atypical Antipsychotics: An Overview.” Grand Rounds, Lewis-Gale Hospital, Salem,
Virginia 1999
“Atypical Antipsychotics: An Overview.” Grand Rounds, Roanoke Memorial Hospital,
Roanoke, Virginia. 1999
“Atypical Antipsychotics: An Overview.” Grand Rounds, Catawba Hospital, Catawba,
Virginia 1999
“Atypical Antipsychotics: An Overview.” Radford, Virginia 1999
“An Update on Antidepressants.” Pfizer Pharmaceuticals, Wilmington, Delaware 1999
“Managing Side Effects of SSRI’s.” Downingtown, Pennsylvania 1999
“Alternative Uses for SSRI’s.” Pfizer Pharmaceuticals, Rehoboth Beach, Delaware 1999
“An Update on Antidepressants.” Grand Rounds, Keypoint Mental Health Clinic,
Baltimore, Maryland 1999
“Ask the Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 1999
“A Comprehensive Review of Traumatic Brain Injury.” Grand Rounds, Springfield
Hospital Center, Sykesville, Maryland 1999
“Depression: What’s Sex Got to do with It?” Baltimore, Maryland. 1999
“Roundtable on Depression and Anxiety.” Southern Chester County Family Practice 1999
“Depression: What’s Sex Got to do with It?” Medical College of Pennsylvania 1999
“Depression: What’s Sex Got to do with It?” Creekwood Center, Abington Hospital,
Willow Grove, Pennsylvania 1999
“Women and Mood Disorders.” Reading, Pennsylvania 1999
“Treating Depression with Modern Technology.” Neurology Grand Rounds,
Christiana Care Health Services, Wilmington, Delaware 1999
“Forensic Psychiatry for the Non-Forensic Psychiatrist.” Crownsville Hospital Center,
Crownsville, Maryland 1999
“Ask the Expert.” Department of Family Practice, Christiana Care Health System,
Wilmington, Delaware 1999
“Depression: What’s Sex Got to do with It? Philadelphia, Pennsylvania 1999
“Forensic Issues in Psychiatry.” Capital Health Systems, Psychiatry Grand Rounds,
Trenton, New Jersey 1999
“Psychiatric Assessment and the Workplace.” MBNA Bank. Wilmington, Delaware 1999
“Latest Advances in the Diagnosis and Treatment of Bipolar Disorder and SADS.”
New Directions, Wilmington, Delaware 1999
“Directions in Behavioral Health.” Rumson, New Jersey for University of Wisconsin
Medical School 1999
“Depression: What’s Sex Got to do with It?” Keypoint Health 1999
“Depression: What’s Sex Got to do with It?” Grand Rounds Lecture, Harford Memorial
Hospital, Havre de Grace, Maryland 1999
“Depression: What’s Sex Got to do with It?” Bryn Mawr, Pennsylvania 1999
“An Overview of Mental Retardation and its Relationship to Functional Competency.”
American Academy of Psychiatry and the Law, 30th Annual Meeting, Baltimore,
Maryland 1999
“Depression: What’s Sex Got to do with It?” Baltimore, Maryland 1999
“Depression: What’s Sex Got to do with It?” Hershey, Pennsylvania 1999
“Successful Management of Anxiety and Depression in Primary Care.” Center for
Healthcare Education, Baltimore, Maryland 1999
“Approaches in Brain Injury: Neuropsychiatric Issues and Updates.” Brain Injury
Association of Delaware Annual Meeting, Wilmington, Delaware 1999
“Dementia and Depression in the Geriatric Population.” Grand Rounds Lecture, Capitol
Health, Dover, Delaware 1999
“Antidepressant Therapy and Tolerability: Contemporary Treatment Strategies.”
Wilmington, Delaware 1999
“The Diagnosis and Treatment of Chronic Depression in Primary Care and Women and
Mood Disorders.” University of Wisconsin Medical School. Willkes-Barre, Pennsylvania 1999
“Women and Mood Disorders and The Diagnosis of Panic/OCD in Primary Care.”
University of Wisconsin Medical School. Philadelphia, Pennsylvania 1999
“Sick Building Syndrome-Fact or Fiction.” Clinical Forensic Psychiatry: Civil and
Criminal Cases. Tri-State Chapter, American Academy of Psychiatry and the Law.
San Juan, Puerto Rico 1999
“Diet and Depression: Food and Migraine.” Wilmington, Delaware 1999
“Depression, Dementia and Neurological Disorders.” Baltimore, Maryland 1999
“Forensic Psychiatry-An Overview.” Grand Rounds Lecture, Hahnemann Hospital,
Department of Psychiatry, Philadelphia, Pennsylvania 1999
“Ask the Expert-Antipsychotics.” Family Practice, Philadelphia, Pennsylvania 2000
“Ask the Expert-Antidepressants.” Family Practice, Philadelphia, Pennsylvania 2000
“Hormones vs. Neurotransmitters: Which Are the Major Culprits in Premenstrual and
Perimenstrual Dysphorias?” Society of Certified Specialists in Psychiatric-Mental Health
Nursing of the New Jersey State Nursing Association. Trenton, New Jersey 2000
“Depression: What’s Sex Got to do with It?” Community Health Network. Baltimore,
Maryland 2000
“Ask the Expert-Antidepressants.” Family Practice, Dilworthtown, Pennsylvania 2000
“Depression: What’s Sex Got to do with It?” Department of Family Practice, Riddle
Memorial Hospital. Chadds Ford, PA 2000
“Post-Traumatic Stress Disorder.” Pfizer Pharmaceuticals. Wilmington, Delaware 2000
“Post-Traumatic Stress Disorder.” Sacred Heart Hospital, Chester, Pennsylvania 2000
“Women, Mood Disorders and PTSD.” Chester Country Hospital, Dilworthtown,
Pennsylvania 2000
“Sex, Mood and Amorous Food.” Wilmington, Delaware 2000
“Anxiety-An Overview for Primary Care Providers.” Grand Rounds Lecture. St. Agnes
Hospital, Philadelphia, Pennsylvania 2000
“Depression: What’s Sex Got to do with It?” Grand Rounds. Department of Medicine,
Taylor Hospital. Ridley Park, Pennsylvania 2000
“Cognitive Complaints in the Elderly.” Assisi House, Marcus Hook, Pennsylvania 2000
“Anxiety-An Overview for Primary Care Providers.” Philadelphia, Pennsylvania 2000
“Depression, Anxiety and PTSD.” Department of OBGYN. Riddle Memorial Hospital,
Dilworthtown, Pennsylvania 2000
“Women, Depression and PTSD.” Philadelphia, Pennsylvania 2000
“Seclusion and Restraint.” Grand Rounds Lecture, Department of Medicine. Franklin
Square Hospital, Baltimore, Maryland 2000
“Sleep Disorders and the Psychiatrist.” Wilmington, Delaware 2000
“Depression and Sexual Disorders.” Allentown, Pennsylvania 2000
“Anxiety: An Overview.” Grand Rounds Lecture. Perry Point VA Hospital. Perry Point,
Maryland 2000
“Post Traumatic Stress Disorder.” Philadelphia, Pennsylvania 2000
“Geriatric Psychiatry: An Overview and Case Discussion.” Department of Family Practice,
St. Francis Hospital. Wilmington, Delaware 2000
“Ask the Expert.” Delaware Brain Injury Association. Wilmington, Delaware 2000
“Depression and Sexual Dysfunction.” Pennsylvania Osteopathic Medical Association
Annual Clinical Assembly, Philadelphia, Pennsylvania 2000
“Depression. What’s Sex Got to do with It?” Pikesville, Maryland 2000
“Depression and PTSD.” The Belmont Center for Comprehensive Treatment,
Philadelphia, Pennsylvania 2000
“Women, Mood Disorders and PTSD.” Department of OBGYN, Paoli Memorial
Hospital, Dilworthtown, Pennsylvania 2000
“Post Traumatic Stress Disorder.” Grand Rounds Lecture. Paoli Memorial Hospital,
Paoli, Pennsylvania 2000
“Depression. What’s Sex Got to do with It?” Annapolis, Maryland 2000
“Depression. What’s Sex Got to do with It?” Baltimore, Maryland 2000
“Geriatric Psychopharmacology.” Nemours Clinic. Wilmington, Delaware 2000
“Ask the Expert.” Southern Chester County Family Practice. Oxford, Pennsylvania 2000
“Appropriate Selection of Antidepressant Therapy.” Christiana Health Care System.
Wilmington, Delaware 2000
“Depression. What’s Sex Got to do with It?” Hunt Valley, Maryland 2000
“Depression. What’s Sex Got to do with It?” Wilmington, Delaware, Maryland 2000
“Hormones, Mood Disorders and PMS.” Grand Rounds Lecture. Department of
Medicine, Riddle Memorial Hospital. Dilworthtown, Pennsylvania 2000
“Innocent Images.” 27th Police Academy Class, New Castle County Police, Wilmington,
Delaware 2000
“Assessment and Management of Unusual Behavior.” 27th Police Academy Class,
New Castle County Police, Wilmington, Delaware 2000
“Seclusion and Restraint.” Grand Rounds Lecture, Springfield Hospital Center,
Sykesville, Maryland 2000
“Depression, Dementia and Management of Aggressive Patients.” Elwyn Incorporated,
Media, Pennsylvania 2000
“Depression. What’s Sex Got to do with It?” Philadelphia, Pennsylvania 2000
“Depression. What’s Sex Got to do with It?” Doylestown, Pennsylvania 2000
“Treatment of Depression and Bipolar Disorders.” Wilmington, Delaware 2000
“Practical Forensic Tips for the Clinician.” University of Pennsylvania Counseling
Center, Philadelphia, Pennsylvania 2000
“Anti-epileptic Treatment of Bipolar Disorder.” Marlton, New Jersey 2000
“Antidepressants-Ask the Expert.” Baltimore, Maryland 2000
“Psychiatric Disorders in Women.” East Greenville, Pennsylvania 2000
“Depression. What’s Sex Got to do with It?” Baltimore, Maryland 2000
“Modern Medical Myths.” Wilmington Delaware 2000
“Depression. What’s Sex Got to do with It?” Grand Rounds Lecture, St. Joseph’s
Hospital, Towson, Maryland 2000
“Psychiatry for the Uninterested Dentist.” Delaware Dental Society, Wilmington, Delaware 2000
“Depression. What’s Sex Got to do with It?” Baltimore, Maryland 2000
“Psychosis in Special Populations.” Wilmington, Delaware 2000
“Dementia for Pharmacists.” Delaware Pharmaceutical Society. Wilmington, Delaware 2000
“Treating Aggression and Violent Patients: Seclusion & Restraint Policies.” Grand
Rounds Lecture. Sheppard Pratt Hospital, Baltimore, Maryland 2000
“Psychosis and Atypical Antipsychotics.” Family Practice Residents Lecture,
Wilmington, Delaware 2001
“Psychiatry for Primary Care.” Wilmington, Delaware 2001
“Psychiatry for Primary Care.” Wilmington, Delaware 2001
“Ask the Expert.” Wilmington, Delaware 2001
“Atypical Antipsychotics.” Dover, Delaware 2001
“Atypical Antipsychotics.” Northern Virginia Mental Health Institute, Fairfax, Virginia 2001
“Atypical Antipsychotics.” Bethesda, Maryland 2001
“Depression and Sexual Dysfunction.” Delaware County Memorial Hospital, Drexel
Hill, Pennsylvania 2001
“Clinical Experience with Atypical Antipsychotics.” Wilmington, Delaware 2001
“Forensic Psychiatry: An Overview.” Academy of Lifelong Learning. Rehoboth Beach,
Delaware 2001
“Clinical Experience with Atypical Antipsychotics.” Dover, Delaware 2001
“Understanding Atypical Antipsychotics, Tardive Dyskinesia and the QT Interval. Cherry
Hill, New Jersey 2001
“Ask the Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2001
“Mental Retardation: An Overview of Diagnosis, Medications and Behavioral Treatment.”
The Benadictines. Wilmington, Delaware 2001
“Post Traumatic Stress Disorder in Medical Settings.” Crozer Chester Burn Center.
Chester, Pennsylvania 2001
“Atypical Antipsychotics.” VA Medical Center, Coatsville, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Grand Rounds Lecture, Atlantic City
Medical Center, Departments of Cardiology and Psychiatry, Atlantic City, New Jersey 2001
“Atypical Antipsychotics.” Gulph Mills, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Grand Rounds Lecture, Norristown
State Hospital. Norristown, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Delaware Psychiatric Center,
Wilmington, Delaware 2001
“Atypical Antipsychotics and their Cardiac Effects.” Gulph Mills, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Philadelphia, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Grand Rounds Lecture, Progressions
Northwestern Psychiatric Institute. Fort Washington, Pennsylvania 2001
“Clinical Differences in Antidepressants.” Wilmington, Delaware 2001
“Atypical Antipsychotics and their Cardiac Effects.” Wrightsville, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Clinton, New York 2001
“Atypical Antipsychotics and their Cardiac Effects.” Utica, New York 2001
“Atypical Antipsychotics and their Cardiac Effects.” Grand Rounds Lecture, Mohawk
Valley Psychiatric Center, Utica, New York 2001
“PTSD-An Overview.” Grand Rounds Lecture, Mohawk Valley Psychiatric Center,
Utica, New York 2001
“Atypical Antipsychotics and their Cardiac Effects.” Grand Rounds Lecture, Hutching’s
Psychiatric Center, Syracuse, New York 2001
“Atypical Antipsychotics and their Cardiac Effects.” Syracuse, New York 2001
“Atypical Antipsychotics and their Cardiac Effects.” Fogelsville, Pennsylvania 2001
“Seclusion and Restraint.” Grand Rounds Lecture, VA Hospital, Perry Point, Maryland 2001
“Advances in the Management of Schizophrenia.” Philadelphia, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Northwest Centers, Mt. Airy,
Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Dilworthtown, Pennsylvania 2001
“Forensic Psychiatry in Everyday Life.” Cokesbury Village, Wilmington, Delaware 2001
“Atypical Antipsychotics and their Cardiac Effects.” Reading, Pennsylvania 2001
“Atypical Antipsychotics and their Cardiac Effects.” Wilmington, Delaware 2001
“SSRI’s-What are the Real Differences?” Wilmington, Delaware 2001
“Update on the Management of Schizophrenia.” Buffalo Psychiatric Center, Buffalo,
New York 2001
“Advances in the Management of Schizophrenia.” Rochester, New York 2001
“Update on the Management of Schizophrenia.” Buffalo Psychiatric Center, Buffalo,
New York 2001
“Advances in the Management of Schizophrenia.” Rochester, New York 2001
“Terrorism and PTSD: Coping with Tragedy.” Wilmington, Delaware 2001
“Advances in the Management of Schizophrenia.” Grand Rounds, Norristown State
Hospital, Norristown, Pennsylvania 2001
“Advances in the Management of Schizophrenia.” National Teleconference 2001
“Bipolar Disorder and Seasonal Affective Disorder.” New Directions, Wilmington, Delaware 2001
“Case Studies in Psychosis and the Use of Atypical Antipsychotics.” Harrisburg State
Hospital, Harrisburg, Pennsylvania 2001
“Advances in the Management of Schizophrenia.” Grand Rounds, Horsham Clinic,
Ambler, Pennsylvania 2001
“Modern Medical Myths.” Dover, Delaware 2001
“Geriatric Psychopharmacology.” Delaware Psychological Association, Wilmington,
Delaware 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Grand Rounds
Lecture, Fairfax Hospital, Falls Church, Virginia 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Grand Rounds
Lecture, Charleston Area Medical Center, Charleston, West Virginia 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Grand Rounds
Lecture, Huntington VA Hospital, Huntington, West Virginia 2001
“Atypical Antipsychotics: A Forensic Clinician’s Perspective.” Huntington, West Virginia 2001
“Challenges and Case Studies in Psychiatry; Receptors in Real People.” Charleston Area
Medical Center, Charleston, West Virginia 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Grand Rounds
Lecture, Mountain Comprehensive Care, Pikeville, Kentucky 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Beckley, West
Virginia 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Wilmington,
Delaware 2001
“Atypical Antipsychotics: What a Primary Care Physician Should Know.” Wilmington,
Delaware 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Roanoke, Virginia 2001
“Review of Psychopharmacology.” Veterans Hospital, Roanoke, Virginia 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Carilion Behavioral
Health Center, Radford, Virginia 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Bluefield, Virginia 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Southern New
Jersey Psychiatric Association, Haddonfield, New Jersey 2001
“SSRI’s: What are the Real Differences?” Wilmington, Delaware 2001
“Atypical Antipsychotics: Clinical and Forensic Issues in Psychiatry.” Grand Rounds
Lecture, Hartford, Connecticut 2001
“Understanding Dementia and Depression.” Alliance to the Medical Society of Delaware,
Annual Meeting, Keynote Speaker. Wilmington, Delaware 2001
“Atypical Antipsychotics: What’s New, What’s Different?” Rye Brook, New York 2001
“Atypical Antipsychotics: What’s New, What’s Different?” Creekwood Center,
Pennsylvania 2001
“PTSD-What’s Changed Since September 11th?” Chadds Ford, Pennsylvania 2001
“Selection and Use of Atypical Antipsychotics in Patients with Dual Diagnoses.”
Philadelphia, Pennsylvania 2001
“PTSD-What’s Changed Since September 11th?” Grand Rounds Lecture, Hospital of the
University of Pennsylvania Trauma Center. Philadelphia, Pennsylvania 2001
“Women, Mood Disorders, Anxiety and PTSD: What Does an OBGYN Need to Know?”
Philadelphia, Pennsylvania 2001
“Atypical Antipsychotics: Clinical and Forensic Issues.” Clark’s Summit, Pennsylvania 2001
“Modern Medical Myths.” Wilmington, Delaware 2001
“Antidepressants: Are Secondary Binding Properties Important?” Philadelphia,
Pennsylvania 2002
“Atypical Antipsychotics and Forensic Issues in the Management of Chronic and
Potentially Violent Patients with Schizophrenia.” Gulph Mills, Pennsylvania 2002
“Atypical Antipsychotics: What’s New, What’s Different.” Grand Rounds Lecture,
Girard Behavioral Medical Group, Philadelphia, Pennsylvania 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Dilworthtown, Pennsylvania 2002
“Understanding Bipolar Disorder.” Marlton, New Jersey 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Newtown, Pennsylvania 2002
“Atypical Antipsychotics: Selection and Switching.” Pfizer Regional Consultants
Meeting, Philadelphia, Pennsylvania 2002
“Atypical Antipsychotics: QTc, What’s All the Fuss About?” Philadelphia, Pennsylvania 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Grand Rounds Lecture, Sheppard
Pratt Hospital, Baltimore, Maryland 2002
“Using the Newer Atypical Antipsychotics.” Richmond, Virginia 2002
“Atypical Antipsychotics: Pearls and Pitfalls.” Fredericksburg, Virginia 2002
“Atypical Antipsychotics: Selection and Switching Strategies.” Marlton, New Jersey 2002
“Atypical Antipsychotics: QTc, What’s All the Fuss About?” Nord Center, Lorain, Ohio 2002
“Using the Newer Atypical Antipsychotics.” Pittsburgh, Pennsylvania 2002
“Using the Newer Atypical Antipsychotics.” Pittsburgh, Pennsylvania 2002
“Optimizing Medical Outcomes in Patients with Schizophrenia.” Grand Rounds Lecture,
Horizon House, Philadelphia, Pennsylvania 2002
“Atypical Antipsychotics: Pearls and Pitfalls.” Philadelphia, Pennsylvania 2002
“Medical-Legal Issues for Mental Health Practitioners.” Grand Rounds Lecture,
Mary Bassett Hospital, Cooperstown, New York 2002
“Advances in Antipsychotic Therapy.” Albany, New York 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Grand Rounds Lecture, Capitol
District Psychiatric Center, Albany, New York 2002
“Advances in Antipsychotic Therapy.” Schenectady, New York 2002
“Seclusion and Restraint and the Proper Treatment of Aggression.” Grand Rounds
Lecture, Albany Memorial Hospital, Menands, New York 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Grand Rounds Lecture,
Samaritan Hospital, Troy, New York 2002
“Comprehensive Management of Individuals with Schizophrenia.” Coral Gables, Florida 2002
“Comprehensive Management of Individuals with Schizophrenia.” Grand Rounds
Lecture, Community Health, Homestead, Florida 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Baltimore, Maryland 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Grand Rounds Lecture,
Clifton T. Perkins Hospital, Maryland 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Northern Virginia Mental Health
Institute, Falls Church, Virginia 2002
“Advances in Antipsychotic Therapy.” McLean, Virginia 2002
Atypical Antipsychotics: Clinical and Forensic Issues.” Grand Rounds Lecture,
VA Affairs Hospital. Martinsburg, West Virginia 2002
“Advances in Antipsychotic Therapy.” Hagerstown, Maryland 2002
“Atypical Antipsychotics: Safety, Efficacy and Clinical Issue.” Tom’s River, New Jersey 2002
“Women and Mental Health: PMS, Depression, SAD, Bipolar Disorder,
Post-Partum Depression, Psychosis.” Hockessin, Delaware 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Nemacolin Woods, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Pittsburgh, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture, Terrell State Hospital, Terrell, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tyler, Texas 2002
“Atypical Antipsychotics in Psychiatric Emergency Service Settings.” Parkland Hospital,
Dallas, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Telecare Services Mental Health/Mental Retardation, Dallas, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Hunt County Mental Health/Mental Retardation, Greenville, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Glen Oaks Hospital, Greenville, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Waco, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Dallas, Texas 2002
“Depression: What’s Sex Got to Do with It?” Grand Rounds Lecture, Albert Einstein
Hospital. Philadelphia, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Green Bay, Wisconsin 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Oshkosh, Wisconsin 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Chicago, Illinois 2002
“Risk Management in the Everyday Use of Atypical Antipsychotics.” Lewes, Delaware 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
McLean Hospital, Belmont, Massachusetts 2002
“Clinically Relevant Forensic Issues.” Grand Rounds Lecture, Psychiatric Group
of Northshore, Danvers, Massachusetts 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
South Bronx Mental Health Council, Bronx, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Rye Brook, New York 2002
“Juvenile Competency Assessment and Restoration.” Grand Rounds Lecture.
Twin Valley Behavioral Healthcare, Columbus, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Columbus, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.
Site One. Marietta, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Vienna, West Virginia 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cincinnati, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cincinnati, Ohio 2002
“PTSD: September 11th: Changed Perspectives.” Trends in Trauma and Cardiovascular
Nursing 2002. MCP Hahnemann University, Philadelphia, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
New Brunswick, New Jersey 2002
“Atypical Antipsychotics: Child and Adolescent Issues.” Northampton, Massachusetts 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Hartford, Connecticut 2002
“Alleged Sexual Abuse in the Context of Divorce.” Grand Rounds Lecture. Vanderbilt
University, Department of Psychiatry. Nashville, Tennessee 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Nashville, Tennessee 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture, Middle Tennessee Mental Health Institute, Nashville, Tennessee 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture, Arizona State Hospital, Phoenix, Arizona 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Phoenix, Arizona 2002
“Advances in the Treatment of Schizophrenia.” Indianapolis, Indiana 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Indianapolis, Indiana 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture, LaRue Carter State Hospital, Indianapolis, Indiana 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture, Roudebush Veterans Administration Medical Center,
Indianapolis, Indiana 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Bloomington, Indiana 2002
“Atypical Antipsychotics: A Roundtable Discussion.” Dilworthtown, Pennsylvania 2002
“The Role of Secondary Binding Properties in the Selection of Antidepressant Therapy.”
Atlantic City, New Jersey 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tampa, Florida, 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tampa, Florida 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Philippine Psychiatrists in America Annual Meeting Keynote Speaker, American
Psychiatric Association Annual Meeting, Philadelphia, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cleveland, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Akron, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Rochester Mental Health Center, Grand Rounds Lecture, Beaver, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Highland Drive Veteran Administration Medical Center, Grand Rounds Lecture,
Pittsburgh, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Pittsburgh, Pennsylvania 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Metropolitan Psychiatric Center, Grand Rounds Lecture, St. Louis, Missouri 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Louis, Missouri 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Louis Psychiatric Rehab Center, Grand Rounds Lecture, St. Louis, Missouri 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Jefferson Barracks Veterans Administration Medical Center, Grand Rounds Lecture,
St. Louis, Missouri 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Louis University Medical Center, St. Louis, Missouri 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Louis, Missouri 2002
“New and Emerging Medications in Psychiatry: Clinical and Financial Issues.” Lehman
Brothers Equity Research. New York, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Northwest Missouri Psychiatric Rehabilitation Center,
Kansas City, Missouri 2002
“Atypical Antipsychotics: Ask the Expert.” Tri-County Mental Health Center. Kansas
City, Missouri 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Kansas City, Missouri 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Comcare of Sedgwick County, Wichita, Kansas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Kansas University Medical School, Wichita, Kansas 2002
“Atypical Antipsychotics and the QT Interval: What’s All the Fuss About?” Prairie View
Mental Health, Newton, Kansas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Wichita, Kansas 2002
“Advances in Atypical Antipsychotic Therapy.” San Diego County Mental Health.
Escondido, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Diego, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. R. J. Donovan Correctional Facility, San Diego, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Diego, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Brookdale Hospital, Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Kingsboro State Mental Institute, Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Woodhull Medical Center, Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Hillside Hospital, Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Rikers Island. Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Long Island College Hospital. Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Brooklyn, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Pilgrim State Hospital. Long Island, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Huntington Station, New York 2002
“Pain, Cognitive Dysfunction, Emotional Sequela and the Aftermath of Traumatic Brain
Injury: Ask the Expert.” Brain Injury Association of Delaware 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Dutchess County Mental Health, Poughkeepsie, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Hudson River Psychiatric Center, Poughkeepsie, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Poughkeepsie, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Mid Hudson Forensic Psychiatric Center, New Hampton, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Congers, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Middletown Psychiatric Center, Middletown, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Rockland County Psychiatric Center, Middletown, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Minrith Clinic, Dallas, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Dallas, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Tenderloin Clinic. San Francisco, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. San Francisco General Hospital. San Francisco, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. San Francisco, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Laureate Clinic. Tulsa, Oklahoma 2002
“Stabilization of the Agitated Patient.” St. Francis Hospital. Tulsa, Oklahoma 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Tulsa, Oklahoma 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Griffin Memorial Hospital, Norman, Oklahoma 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Oklahoma City, Oklahoma 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Oklahoma City, Oklahoma 2002
“Management of Acute Agitation in the Emergency Room.” Parkland Memorial Hospital.
Dallas, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Dallas, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Omaha, Nebraska 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Douglas County Hospital, Omaha, Nebraska 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. University of New Mexico Health Sciences Center, Albuquerque,
New Mexico 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Albuquerque, New Mexico 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Veterans Administration Hospital. Tucson, Arizona 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tucson, Arizona 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. William Beaumont Army Hospital. El Paso, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Texas Tech Medical Center-El Paso Psychiatric Center.
El Paso, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Christ Hospital, Oak Lawn, Illinois 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Prairie Community Mental Heath Center. Chicago Heights
Illinois. 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Ingall’s Hospital. Harvey, Illinois. 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Oakbrook, Illinois 2002
“Therapeutic Advances in the Clinical Management of Depression.” Wilmington, Delaware 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Blue Ridge Mental Health. Asheville, North Carolina 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Winston Salem, North Carolina 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.” Park
Ridge Hospital. Asheville, North Carolina 2002
“Beyond the Acute Phase: Issues in Stabilization of the Individual with Psychosis.”
Asheville, North Carolina 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.” Grand
Rounds Lecture. Broughton State Hospital, Morganton, North Carolina 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Hickory, North Carolina 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. High Point Mental Health Center, Greensboro, North Carolina 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.” Grand
Rounds Lecture. Salisbury Veterans Medical Center, Greensboro, North Carolina 2002
“Beyond the Acute Phase: Issues in Stabilization of the Individual with Psychosis.”
Greensboro, North Carolina 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.” Grand
Rounds Lecture. Camden County Health Services Center, Blackwood, New Jersey 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Rancocas Hospital. Rancocas, New Jersey 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Atlantic Behavioral Health. Atlantic City, New Jersey 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Ripley Mental Health and Mental Retardation. Houston, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Houston, Texas 2002
“Atypical Antipsychotics in Medically Ill Patients.” MD Anderson Cancer Institute.
Houston, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Houston, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Harris County Mental Health Retardation Authority. Houston, Texas 2002
“Atypical Antipsychotics: IM, Pediatric and Medical-Legal Issues.”
Harris County Mental Health Retardation Authority. Houston, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Houston, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
University Behavioral Health. Houston, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Eastern States Hospital. Williamsburg, Virginia 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Norfolk, Virginia 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Hampton, Virginia 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Newport News, Virginia 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Metropolitan State Hospital. Norwalk, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Veterans Affairs Hospital. Long Beach, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Redondo Beach, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cedars-Sinai Medical Center, Los Angeles, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Sherman Oaks, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Los Angeles, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Olive View-UCLA Medical Center. Sylmar, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Kern Medical Center. Bakersfield, California 2002
“Atypical Antipsychotics in the Correctional Setting.” California Correctional Institute.
Bakersfield, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Santa Barbara, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Bronx State Psychiatric Hospital. Bronx, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Rye. Bronx, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Lincoln Hospital. South Bronx, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Rye, New York 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Washington, D.C. 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
McAllen, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Harlingen Mental Health-Mental Retardation. Harlingen, Texas 2002
““Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tropical Mental Health. Harlingen, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Corpus Christi, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Austin State Hospital, Austin, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Austin, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Kerrville State Hospital. Kerrville, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Antonio, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Antonio Veterans Affairs Hospital. San Antonio, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Antonio, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Mental Health-Mental Retardation Clinic. San Antonio, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Antonio State Hospital. San Antonio, Texas 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Prescott Health Care Center. Worcester, Massachusetts 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Framingham, Massachusetts 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Lowell, Massachusetts 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Concord, New Hampshire 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Southern Maine Medical Center. Biddeford, Maine 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Portland, Maine 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Veterans Administration Medical Center, East Orange, New Jersey 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Westfield, New Jersey 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
California State Prison at San Quentin. Marin, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Solano County Mental Health Clinic. Vallejo, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Napa, California 2002
“Videotaping Forensic Examinations.” Annual Meeting of the American Academy of
Psychiatry and the Law. Newport Beach, California 2002
“A 15 Year Follow-up to Rivers v. Katz.” Paper and data of Richard Ciccone, M.D.
Annual Meeting of the American Academy of Psychiatry and the Law.
Newport Beach, California 2002
“Psychopharmacology of Traumatic Brain Injury.” Annual Meeting of the Brain Injury
Association of Delaware. Dover, Delaware 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Recovery Resources. Cleveland, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Akron, Ohio 2002
“Clinical Experience with Atypical Antipsychotics.” Center for Family and Children.
Parma, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Community Support Services. Akron, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cleveland, Ohio 2002
“Atypical Antipsychotics: Clinical Roundtable.” Mansfield, Ohio. 2002
“Atypical Antipsychotics: Clinical Roundtable.” Shepherd Hill Hospital. Columbus, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Columbus, Ohio 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
University Community Medical Center. San Diego, California 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Rancho Santa Fe, California 2002
“From the Acute Phase to Maintenance, The Advancements in the Management of the
Agitated Psychotic Patient.” Grand Rounds Lecture. Hawaii State Hospital. Kaneohe,
Hawaii 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Honolulu, Hawaii 2002
“From the Acute Phase to Maintenance, The Advancements in the Management of the
Agitated Psychotic Patient.” Grand Rounds Lecture. VA Medical Center Hospital.
Honolulu, Hawaii 2002
“Atypical Antipsychotics: Multiple Drugs, Multiple Indications, Multiple Uses.” Kahi Mohala
Behavioral Health. Ewa Beach, Hawaii 2002
“From the Acute Phase to Maintenance, The Advancements in the Management of the
Agitated Psychotic Patient.” Honolulu, Hawaii 2002
“Ask the Expert-Clinical Issues in the Management of Psychosis.” Community Mental
Health Center. Memphis, Tennessee 2002
“Comprehensive Management of Psychosis and Schizophrenia.” Memphis, Tennessee 2002
“Assessment and Treatment of Aggression and Psychosis.” Spring Grove State Hospital.
Cantonsville, Maryland 2002
“Assessment and Treatment of Aggression and Psychosis.” Grand Rounds Lecture.
Franklin Square Hospital. Baltimore, Maryland 2002
“Atypical Antipsychotics: Multiple Drugs, Multiple Indications, Multiple Uses.” Baltimore,
Maryland 2002
“Atypical Antipsychotics: Clinical and Forensic Issues.” Community Network Services.
Detroit, Michigan 2002
“Management of Schizophrenia.” Detroit, Michigan 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Northwestern Hospital. Evanston, Illinois 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Lake Cook Behavioral Health. Illinois 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Chicago, Illinois 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Oshkosh, Wisconsin 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Rhinelander, Wisconsin 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Chicago, Illinois 2002
“New Advancements in Atypical Antipsychotics.” Highwood, Illinois 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture, Regions Hospital. St. Paul, Minnesota 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Paul, Minnesota 2002
“Treatment of the Acutely Agitated Patient in the Emergency Room.” Fairview Southdale
Hospital. Edwina, Minnesota 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Duluth, Minnesota 2002
“Atypical Antipsychotics and the Refractory Patient.” St. Peter Regional Treatment Center.
St. Peter, Minnesota 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Paul, Minnesota 2002
“The Personal and Fiscal Costs of the Right to Refuse Treatment.” Minneapolis, Minnesota 2002
“Atypical Antipsychotics and the Management of Acute Agitation on an Inpatient Unit.”
Mercy Hospital. Coon Rapids, Minnesota 2002
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Aiken Mental Health. Aiken, South Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture, Georgia Regional Mental Health. Augusta, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Augusta, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Atlanta, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Mood Disorder Clinic of Snellville. Snellville, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Beaufort Mental Health Clinic, Beaufort. South Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Veterans Administration Medical Center, Charleston, South
Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Charleston, South Carolina 2003
“Advances in Oral & IM Atypical Antipsychotics.” Blue Ridge Behavioral Health.
Roanoke, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Roanoke, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Southwest Virginia Mental Health Institute. Marion, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Radford, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Danville, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Lynchburg, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Keypoint Community Mental Health Center. Dundalk, Maryland 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Baltimore, Maryland 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Petersburg, Florida 2003
“Comprehensive Management of Schizophrenia and Psychosis.”
Clearwater, Florida 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tampa, Florida 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tampa, Florida 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Community Mental Health Center. Jacksonville, Florida 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Simons Island, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Jacksonville, Florida 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Jacksonville, Florida 2003
“Atypical Antipsychotics: Clinical Overview and Case Conference.” Dilworthtown,
Pennsylvania 2003
“Beyond the Acute Phase: Issues in Stabilization of the Individual with Schizophrenia.”
Bruneswick Hospital Outpatient Clinic. Amityille, New York 2003
“Recent Advances in the Management Schizophrenia.” Farmingdale, New York 2003
“Beyond the Acute Phase: Issues in Stabilization of the Individual with Schizophrenia.”
Mercy Day Program. Uniondale, New York 2003
“Utilizing Antipsychotics in Acute Agitation.” Grand Rounds Lecture. Northshore
University Hospital. Manhasset, New York 2003
“Atypical Antipsychotics: Clinical Overview and Case Conference.” Utah State
Hospital. Provo, Utah 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Salt Lake City, Utah 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
East Valley Mental Health Clinic. Salt Lake City, Utah 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
University of Utah Medical School. Salt Lake City, Utah 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Bethesda, Maryland 2003
“Treatment of Aggression and Psychosis: Clinical and Forensic Issues.” Grand Rounds
Lecture. St. Elizabeth’s Hospital, Washington, D.C. 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tysons Corner, Virginia 2003
“Recognition and Treatment of Depression in Primary Care.” Wilmington, Delaware 2003
“Recognition and Treatment of Depression in Primary Care.” Dover, Delaware 2003
“Recognition and Treatment of Depression in Primary Care.” Wilmington, Delaware 2003
“Treatment of Aggression and Psychosis: Clinical and Forensic Issues.” Grand Rounds
Lecture. University of Alabama at Birmingham. Birmingham, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Birmingham, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Birmingham, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
North Alabama Regional Hospital. Decauter, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Mental Health Center. Huntsville, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Florence, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Madison, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Bryce Hospital. Tuscaloosa, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tuscaloosa, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tuscaloosa, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Carraway Medical Center. Birmingham, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Mountain View Hospital. Gadsden, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Anniston, Alabama 2003
“Atypical Antipsychotics: Forensic Overview and Clinical Case Presentation.” Newark,
Delaware 2003
“Atypical Antipsychotics: Forensic Overview and Clinical Case Presentation.” Jefferson
Regional Medical Center. Pittsburgh, Pennsylvania 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Mon Yough Mental Health Center. Pittsburgh, Pennsylvania 2003
“Comparative Effectiveness of Antipsychotic Drugs: What are the Real Differences?”
Pittsburgh, Pennsylvania 2003
“Diabetes, Erectile Dysfunction and Psychotropic Medications: Case Studies.” American
Diabetes Association Diabetes Update 2003. Wilmington, Delaware 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Little Rock, Arkansas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Little Rock, Arkansas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Memphis, Tennessee 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Memphis, Tennessee 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Laurelwood Mental Health Center. Gainesville, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Atlanta, Georgia 2003
“Comprehensive Management of Individuals with Psychosis.” Jackson, Mississippi 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Greenville Mental Health Center. Greenville, South Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Greenwood, South Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Pat B. Harris Psychiatric Hospital. Anderson, South Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Columbia, South Carolina 2003
“Antidepressants: Are Secondary Binding Properties Important? Evansville, Indiana 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Evansville, Indiana 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
CARITAS Peace Hospital. Louisville, Kentucky 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Louisville, Kentucky 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cleveland, Ohio 2003
“Acetylcholinesterase Inhibitors: Life Beyond Alzheimer’s.” Cleveland, Ohio 2003
“Atypical Antipsychotics: Risk Management Issue.” Grand Rounds Lecture. Metropolitan
Hospital. Cleveland, Ohio 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cleveland, Ohio 2003
“Antidepressants: Are Secondary Binding Properties Important? Grand Rounds Lecture.
Tucson Veterans Administration Hospital. Tucson, Arizona 2003
“Antidepressants: Are Secondary Binding Properties Important? Tucson, Arizona 2003
“Atypical Antipsychotics: Risk Management Issue.” Grand Rounds Lecture. Metropolitan
Hospital. Cleveland, Ohio 2003
“Atypical Antipsychotics: Forensic Issues.” Grand Rounds Lecture. Arizona State Hospital.
Phoenix, Arizona 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Phoenix, Arizona 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Phoenix, Arizona 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cascadia Community Mental Health Center. Portland, Oregon 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Portland, Oregon 2003
“Atypical Antipsychotics in Forensic Settings.” San Francisco General Hospital Prison
Ward. San Francisco, California 2003
“Antidepressants: Are Secondary Binding Properties Important? San Francisco, California 2003
“Atypical Antipsychotics: The Risk Management Game.” Grand Rounds Lecture. Kansas
University Department of Psychiatry. Wichita, Kansas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Wichita, Kansas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Topeka Community Mental Health Center. Topeka, Kansas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Topeka, Kansas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Northwest Missouri Psychiatric Rehab. Kansas City, Missouri 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Kansas City, Kansas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Kansas University, Kansas City, Missouri 2003
“Aggression and Violence.” Central State Hospital. Petersburg, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Richmond, Virginia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Summitt Behavioral Health. Cincinnati, Ohio 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Dayton, Ohio 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Veterans Affairs Medical Center. Cincinnati, Ohio 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Cincinnati, Ohio 2003
“Depression and Cardiovascular Disease: The Role of Antidepressant Therapy.”
Tuscaloosa, Alabama 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Houston, Texas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
University of Texas Behavioral Health Sciences Center. Houston, Texas 2003
“Atypical Antipsychotics-State of the Art.” Houston, Texas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Houston, Texas 2003
“Aggression and Violence.” Chartres Mental Health Clinic. New Orleans, Louisiana 2003
“Aggression and Violence.” New Orleans, Louisiana 2003
“Aggression and Violence.” West Jefferson Medical Center, New Orleans, Louisiana 2003
“Aggression and Violence.” Terrebone Mental Health Center, Houma, Louisiana 2003
“Aggression and Violence.” Houma, Louisiana 2003
“Aggression and Violence.” New Orleans Adolescent Hospital. New Orleans, Louisiana 2003
“Atypical Antipsychotics in the Forensic Setting.” Mid Hudson Forensic State Hospital.
Middletown, New York 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Newburgh, New York 2003
“Beyond the Acute Phase: Issues in Stabilization of the Individual with Schizophrenia.”
Maine Medical Center. Portland, Maine 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Portland, Maine 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. St. Mary’s Hospital. Lewiston, Maine 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Brewer, Maine 2003
“Risk Assessment and Management with Atypical Antipsychotics.” University of New
Mexico. Albuquerque, New Mexico 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Santa Fe, New Mexico 2003
“Depression and Cardiovascular Disease: The Role of Antidepressant Therapy.”
Jefferson County Mental Health. Denver, Colorado 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Boulder, Colorado 2003
“The Personal and Fiscal Costs of the Right to Refuse Treatment.” Grand Rounds Lecture,
Colorado State Hospital at Pueblo. Pueblo, Colorado 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Boulder, Colorado 2003
“The Risk Game: Assessing Clinical and Forensic Implications of Atypical Antipsychotics.”
Veterans Administration Hospital. Denver, Colorado 2003
“Geriatric Psychopharmacology.” Wesley Woods Geriatric Health Center, Emory University
Medical Center. Atlanta, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Atlanta, Georgia 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Northwest Georgia Regional Hospital. Rome, Georgia 2003
“Atypical Antipsychotics: Ask the Expert.” Peachford Mental Health. Atlanta, Georgia 2003
“Atypical Antipsychotics and the Management of Aggression in the Medical ER.” Atlanta,
Georgia 2003
“Atypical Antipsychotics: Ask the Expert.” Christian Health Care. Wycoff, New Jersey 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
St. Charles Hospital. Denville, New Jersey 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Morristown, New Jersey 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
FEGS Mental Health Center. Bronx, New York 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Hastings On Hudson, New York 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Northern Rhode Island Mental Health Center. Woonsocket, Rhode Island 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Providence, Rhode Island 2003
“Strategies for Treatment Resistant Schizophrenia.” Grand Rounds Lecture. Manhattan
Psychiatric Center. New York, New York 2003
“Atypical Antipsychotics: Ask the Expert.” New York Psychiatric Institute.
New York, New York 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
New York, New York 2003
“Depression and Bipolar Disorder: Biological Theories, Psychopharmacology and
Expert Advice.” New Directions Delaware. Wilmington, Delaware 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Grand Rounds Lecture. Capitol Region Mental Health Center. Hartford, Connecticut 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Hartford, Connecticut 2003
“Advances in Atypical Antipsychotics.” Austin, Texas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Austin, Texas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Antonio, Texas 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
San Antonio, Texas 2003
“Advances in Atypical Antipsychotics. Milwaukee, Wisconsin 2003
“Atypical Antipsychotics in the Criminal Justice System.” Dover, Delaware 2003
“Atypical Antipsychotics: Ask the Expert. Chicago, Illinois 2003
“Atypical Antipsychotics: Ask the Expert. Chicago, Illinois 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Chicago, Illinois 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Read Psychiatric Hospital. Chicago, Illinois 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Chicago, Illinois 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Lutheran General Hospital. Chicago, Illinois 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Chicago, Illinois 2003
“Atypical Antipsychotics: Ask the Expert. VA Hospital. Chicago, Illinois 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Chicago, Illinois 2003
“Atypical Antipsychotics: Clinical Case Discussion.” Princeton, New Jersey 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Horsham Hospital. Norristown, Pennsylvania 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Norristown, Pennsylvania 2003
“Current Controversies in Prescribing Atypical Antipsychotics.” Annual Meeting of the
American Academy of Psychiatry and the Law. San Antonio, Texas 2003
“Right to Refuse Treatment.” NYS OMH Training. Utica, NY 2003
“Aggression and Violence in Maximum Security Facilities.” NYS OMH Training, Utica, NY 2003
“Right to Refuse Treatment.” NYS OMH Training. Batavia, NY 2003
“Aggression and Violence in Maximum Security Facilities.” NYS OMH Training, Batavia, NY 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Veterans Affairs Medical Center. Tacoma, Washington 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Tacoma, Washington 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Harborview Medical Center. Seattle, Washington 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Seattle, Washington 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Spokane, Washington 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Spokane, Washington 2003
“Atypical Antipsychotics: Case Presentations.” Cherry Hill, New Jersey 2003
“Atypical Antipsychotics: Focus on Adolescents.” New York Society of Adolescent
Psychiatrists. New York, New York 2003
“Practical Answers from a Psychiatrist.” Temple Beth El. Newark, DE 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Charleston, South Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Charleston, South Carolina 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Columbia, South Carolina 2003
“Evaluating Delaware’s Involuntary Commitment Process.” Delaware State Troopers
Association and Delaware Department of Justice. Smyrna, Delaware 2003
“Differentiating Between Antidepressants.” Muncie, Indiana 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Fort Wayne, Indiana 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Logansport State Hospital. Logansport, Indiana 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
New Haven, Connecticut 2003
“Atypical Antipsychotics: Efficacy, Safety and Dosing: Clinical and Forensic Issues.”
Bridgeport Hospital. Bridgeport, Connecticut 2003
“Advances in Atypical Antipsychotics.: Blue Bell, Pennsylvania 2003
“Advances in Atypical Antipsychotics.: Creekwood Center. Willow Grove, Pennsylvania 2003
“Advances in Atypical Antipsychotics.: Princeton, New Jersey 2003
“Medicine for Lawyers: Traumatic Brain Injury Cases.” New Jersey Institute for Continuing
Legal Education. Cherry Hill, New Jersey 2003
“The Right to Refuse Treatment.” Delaware Psychiatric Center. Wilmington, Delaware 2003
“Atypical Antipsychotics: Different Drugs: Different Risks.” Mobile, Alabama 2004
“Atypical Antipsychotics: Different Drugs: Different Risks.” Pensacola, Florida 2004
“Atypical Antipsychotics: Different Drugs: Different Risks.” Pensacola, Florida 2004
“Atypical Antipsychotics: Different Drugs: Different Risks.” Atlanta, Georgia 2004
“Atypical Antipsychotics: Different Drugs: Different Risks.” Sarasota, Florida 2004
“Atypical Antipsychotics: A Critical Review.” Ruth Cooper Center. Ft. Myers, Florida 2004
“Atypical Antipsychotics: Different Drugs: Different Risks.” Sarasota, Florida 2004
“Atypical Antipsychotics: Different Drugs: Different Risks.” South County Mental Health,
Delray, Florida 2004
“Atypical Antipsychotics: Different Drugs: Different Risks.” Florida Psychiatric Society.
Ft. Lauderdale, Florida 2004
“The Right to Refuse Treatment.” NYS OMH Training. Saratoga Springs, New York 2004
“Biology and Treatment of Aggression and Violence in Maximum Security Facilities.”
NYS OMH Training. Saratoga Springs, New York 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Boca Raton,
Florida 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Hollywood,
Florida 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Henderson
Mental Health. Fort Lauderdale, Florida 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Phoenix, Arizona 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Scottsdale, Arizona 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Flagstaff Guidance
Center. Flagstaff, Arizona 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Paradise Valley,
Arizona 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Norfolk, Virginia 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Newport News,
Virginia 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Norfolk, Virginia 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Norfolk, Virginia 2004
“Post-Traumatic Stress Disorder.” Widener University School of Law. Wilmington, Delaware 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Lewes, Delaware 2004
“Second Generation Antipsychotics: Clinical and Forensic Issues.” Grand Rounds Lecture.
Spring Grove Hospital. Catonsville, Maryland 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Tulsa, Oklahoma 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Comcare
Mental Health. Wichita, Kansas 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Kansas City,
Missouri 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Osawatomie State
Hospital. Osawatomie, Kansas 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Wichita, Kansas 2004
“Mad or Bad? Mental Health and the Criminal Justice System.” Grand Rounds Lecture.
Delaware Psychiatric Center. New Castle, Delaware 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Roanoke, Virginia 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Southern State
Hospital. Danville, Virginia 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Piedmont
Psychiatric. Lynchberg, Virginia 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Houston, Texas 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Beaumont, Texas 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Clear Lake, Texas 2004
“Second Generation Antipsychotics: Ask the Expert.” Southeast Mental Health Clinic.
Houston, Texas 2004
“Secondary Binding Properties of Antidepressant Medications: Clinical Relevance for the
Primary Care Physician.” Wilmington, Delaware 2004
“Women and Mood Disorders: Medications and Pregnancy.” Wilmington, Delaware 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” St. Barnabas Hospital. Toms River, New Jersey 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Spring Lake,
New Jersey 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Harrisburg, Pennsylvania 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Lancaster,
Pennsylvania 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” West Yavapai Guidance Clinic. Prescott, Arizona 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Mesa, Arizona 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Banner Behavioral Health. Phoenix, Arizona 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Scottsdale, Arizona 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Phoenix, Arizona 2004
“Forensic Psychiatry: An Overview for Non-Forensic Psychiatrists.” Grand Rounds Lecture.
University of Utah, College of Medicine. Salt Lake City, Utah 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Salt Lake City, Utah 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Intermountain Hospital. Boise, Idaho 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Boise, Idaho 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Wyoming State Hospital. Evanston, Wyoming 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Douglas County Mental Health. Alexandria, Minnesota 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Minneapolis, Minnesota 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Willmar, Minnesota 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Waite Park, Minnesota 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Abbott Northwestern Hospital. Minneapolis, Minnesota 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” St. Peter, Minnesota 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Forbes Regional Hospital. Pittsburgh, Pennsylvania 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” LifeCare Hospital. Pittsburgh, Pennsylvania 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Pittsburgh, Pennsylvania 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Beaver Hospital. Beaver, Pennsylvania 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Pittsburgh, Pennsylvania 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” New York, New York 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” New York, New York 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” New York, New York 2004
“Second Generation Antipsychotics: Different Drugs: Different Risks. Consensus Guidelines
for Safe Use.” Veterans Affairs Hospital. Coatesville, Pennsylvania 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Chicago, Illinois 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Lutheran General Hospital.
Chicago, Illinois 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Chicago Read State
Psychiatric Clinic. Chicago, Illinois 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Chicago, Illinois 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Alaska Psychiatric
Institute. Anchorage, Alaska 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Anchorage, Alaska 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Providence Behavioral
Health. Wasilla, Alaska 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Providence Hospital.
Anchorage, Alaska 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Anchorage, Alaska 2004
“The Historical and Practical Context of Patient and Provider Rights.” Central New York
Psychiatric Center. Fishkill, New York. 2004
“Management of Aggression and Agitation: Pharmacological and Non-Pharmacological
Interventions.” Central New York Psychiatric Center. Fishkill, New York. 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Morristown, New Jersey 2004
“Ask the Brain Injury Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Laureate Hospital.
Tulsa, Oklahoma 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Tulsa, Oklahoma 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Main Street Mental Health.
Fort Worth, Texas 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Fort Worth, Texas 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” John Paul Smith Hospital.
Fort Worth, Texas 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Fort Worth, Texas 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Tarrant County Mental
Health Clinic. Fort Worth, Texas 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Cooks Children’s Center.
Fort Worth, Texas 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Santa Clara County Mental
Health Clinic. San Jose, California 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” San Jose, California 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” San Francisco, California 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” San Francisco, California 2004
“Second Generation Antipsychotics: From Basic Science to the Bedside.” Grand Rounds
Lecture. Veterans Affairs Hospital. Long Beach, California 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Los Angeles, California 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Sharp Mesa Vista Hospital.
San Diego, California 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” La Jolla, California 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Eugenia Hospital
Lafayette Hills, Pennsylvania 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Valley Forge, Pennsylvania 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Princeton, New Jersey 2004
“Ask the Expert: Roundtable Discussion on Psychopharmacology and Forensic Medicine.”
New Brunswick, New Jersey 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Mendota Mental Health
Institute. Madison, Wisconsin 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Madison, Wisconsin 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Milwaukee, Wisconsin 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Medical College of
Wisconsin. Milwaukee, Wisconsin 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Milwaukee, Wisconsin 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Milwaukee, Wisconsin 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” New Haven, Connecticut 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” New Haven, Connecticut 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Bridgeport, Connecticut 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Waterbury, Connecticut 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Trumball, Connecticut 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” West Bergen, New Jersey 2004
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Hackensack, New Jersey 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” St. Joseph’s Hospital.
Dickenson, North Dakota 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Bismarck, North Dakota 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Human Service Center.
Jamestown, North Dakota 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Minot, North Dakota 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Fargo, North Dakota 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Altru Hospital. Thief
River Falls, Minnesota 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Richard Hall Community
Mental Health Center. Sommerville, New Jersey 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Newport News, Virginia 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Eastern State Hospital.
Williamsburg, Virginia 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Norfolk, Virginia 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Hunterdon Behavioral
Health Center. Flemington, New Jersey 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Princeton, New Jersey 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Nesbitt Memorial Hospital.
Wilkes-Barre, Pennsylvania 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Wilkes-Barre,
Pennsylvania 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Kidspeace Hospital.
Orefield, Pennsylvania 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Bethlehem,
Pennsylvania 2004
“Advances in Atypical Antipsychotics: From Basic Science to the Bedside: Clinical and Forensic
Issues. Best Practices in Psychopharmacology and Treatment. Community Health and
Behavioral Services. Utica, New York 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Syracuse, New York 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Crozer-Chester Hospital.
Chester, Pennsylvania 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Horsham Clinic.
Ambler, Pennsylvania 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Lafayette Mental Health
Clinic. Lafayette, Louisiana 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Lafayette, Louisiana 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” East Louisiana State
Mental Hospital. Baton Rouge, Louisiana 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Baton Rouge,
Louisiana 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Snellville, Georgia 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Wilmington, Delaware 2004
“Long Term Management of Schizophrenia.” Newark, Delaware 2004
“Update on Pharmacological Treatments for Brain Injury.” Brain Injury Association of
Delaware, Annual Meeting. Dover, Delaware 2004
“Peer Review of Psychiatric Testimony: Head Injury.” Annual Meeting of the American
Academy of Psychiatry and the Law. Scottsdale, Arizona 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Manatee Glens Hospital.
Bradenton, Florida 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Naples, Florida 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Citrus Mental Health.
Hialeah, Florida 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Miami, Florida 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Tamarac, Florida 2004
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Fort Lauderdale,
Florida 2004
“Challenges in the Treatment of Bipolar Disorder.” San Antonio State Hospital.
Kerrville, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” San Antonio, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” University Hospital. San Antonio, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Austin, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Austin State Hospital. Austin, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Southwest Mental Health Clinic.
Austin, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Virginia Beach, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Eastern State Hospital. Williamsburg,
Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Portsmouth, Virginia 2005
“Depression and Agitation in Primary Care.” Sentara Virginia Beach General Hospital.
Virginia Beach, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Newport News, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Lewes, Delaware 2005
“Forensic Psychiatry for the Lay Person.” Rotary International, Newark, Delaware 2005
“Challenges in the Treatment of Bipolar Disorder.” Lewis Gale Hospital. Roanoke, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Radford, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Grand Rounds Lecture. Southern Virginia
Mental Health Institute. Danville, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Roanoke, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Southern Highlands Mental Health.
Princeton, West Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Huntington, Virginia 2005
“Challenges in the Treatment of Bipolar Disorder.” Savannah, Georgia 2005
“Challenges in the Treatment of Bipolar Disorder.” Savannah Area Behavioral Mental Health
Center. Savannah, Georgia 2005
“Challenges in the Treatment of Bipolar Disorder.” Palmetto Behavioral Health. Charleston,
South Carolina. 2005
“Challenges in the Treatment of Bipolar Disorder.” Charleston, South Carolina. 2005
“Challenges in the Treatment of Bipolar Disorder.” Georgetown Mental Health Center.
Georgetown, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Myrtle Beach, South Carolina. 2005
“Challenges in the Treatment of Bipolar Disorder.” Richard Hall Mental Health Center.
Bridgewater, New Jersey 2005
“Challenges in the Treatment of Bipolar Disorder.” Lawrenceville, New Jersey 2005
“Anxiety Disorders.” New Directions Delaware. Wilmington, Delaware 2005
“An Overview of Geriatric Psychiatry.” Oklahoma Psychiatric Association Annual
Meeting. Tulsa, Okalahoma 2005
“Depression and Bipolar Disorder in Geriatrics.” Oklahoma Psychiatric Association Annual
Meeting. Tulsa, Okalahoma 2005
“Cognitive Disorders in Geriatric Patients.” Oklahoma Psychiatric Association Annual Meeting.
Tulsa, Okalahoma 2005
“Psychosis in the Geriatric Patient.” Oklahoma Psychiatric Association Annual Meeting.
Tulsa, Okalahoma 2005
“Geriatric Psychopharmacology.” Oklahoma Psychiatric Association Annual Meeting.
Tulsa, Okalahoma 2005
“Forensic Geriatric Psychiatry.” Oklahoma Psychiatric Association Annual Meeting.
Tulsa, Okalahoma 2005
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic or Mixed Episodes”. Mission Hospital. Asheville, North Carolina 2005
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic or Mixed Episodes”. Asheville, North Carolina 2005
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic or Mixed Episodes”. Broughton St. Joseph’s Hospital. Morganton, North Carolina 2005
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic or Mixed Episodes”. Roanoke, Virginia 2005
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic or Mixed Episodes”. Community Service Board. Harrisonberg, Virginia 2005
“Evidence Based Medicine.” Wilmington, Delaware 2005
“Why Antipsychotics Don’t Work.” Wilmington, Delaware 2005
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic or Mixed Episodes”. Williamsburg, Virginia 2005
“Depression and Bipolar Disorder”. Center for Psychiatry and Addiction Treatment. Prince
William Hospital. Manassas, Virginia 2005
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic or Mixed Episodes”. Old Town Alexandria, Virginia 2005
“Depression and Bipolar Disorder”. Prince William Hospital. Stafford, Virginia 2005
“Advancing Your Options in the Treatment of Acute Bipolar Manic and Mixed Episodes.
Metro State Prison/Fulton County Jail. Atlanta, Georgia 2005
“Advancing Your Options in the Treatment of Acute Bipolar Manic and Mixed Episodes.
Central State Hospital. Miledgeville, Georgia. 2005
“Advancing Your Options in the Treatment of Acute Bipolar Manic and Mixed Episodes.
Macon, Georgia 2005
“Advancing Your Options in the Treatment of Acute Bipolar Manic and Mixed Episodes.
Dougherty County Mental Health. Albany, Georgia 2005
“Advancing Your Options in the Treatment of Acute Bipolar Manic and Mixed Episodes.
Community Mental Health of Middle Georgia. Dublin, Georgia 2005
“Depression and Dementia Syndromes in Primary Care.” Dilworthtown, Pennsylvania 2005
“Evidence Based Medicine.” Lewes, Delaware 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Chicago, Illinois 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Chicago, Illinois 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Chicago, Illinois 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Atlanta, Georgia 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Atlanta, Georgia 2005
“Medical/Legal Considerations of Treating with SSRI’s.” Atlanta, Georgia 2005
“Ask the Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Lansing, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Kalamazoo Psychiatric
Hospital. Kalamazoo, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Decateur, Michigan 2005
“Differences between the SSRI’s.” Grand Rapids, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Caro, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Saginaw, Michigan 2005
“Cognition and Atypical Antipsychotics.” Grand Rounds lecture. Morristown Memorial
Hospital. Morristown, New Jersey 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” St. Clare’s Hospital.
Boonton, New Jersey 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Morristown, New Jersey 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Circle of Life Hospital.
Detroit, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Detroit, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” CMHC. Detroit,
Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Holy Spirit Behavioral
Health Hospital. Harrisburg, Pennsylvania 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” East Petersburg,
Pennsylvania 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Searcy State Hospital.
Mobile, Alabama 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Mobile, Alabama 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Midland, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Flint, Michigan 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Phoenix, Arizona 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Prescott, Arizona 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Banner Behavioral
Scottsdale. Scottsdale, Arizona 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Banner Desert
Behavioral. Mesa, Arizona 2005
“Atypical Antipsychotics in Acute Bipolar Mania, Managing Symptoms and Minimizing Adverse
Events: the Beginning of Successful Treatment. Phoenix, Arizona 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Desert Vista
Behavioral Health. Mesa, Arizona 2005
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Bryn Mawr, Pennsylvania 2005
“Ziprasidone IM in Acute Psychosis.” Wilmington, Delaware 2005
“Quetiapine in Bipolar Disorder.” Wilmington, Delaware 2005
“Challenges in the Treatment of Bipolar Disorder.” Bryan, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Huntsville, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Waco, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Waco Mental Health Center. Waco, Texas 2005
“Challenges in the Treatment of Bipolar Disorder.” Spartenburg Mental Health Center.
Spartenburg, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Greenville, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Greenville Mental Health Center.
Greenville, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Anderson, South Carolina 2005
“Sertaline in Special Populations.” Wilmington, Delaware 2005
“Challenges in the Treatment of Bipolar Disorder.” Columbia, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Medical University of South Carolina.
Charleston, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Clarendon Mental Health Center.
Charleston, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Charleston, South Carolina 2005
“Challenges in the Treatment of Bipolar Disorder.” Affiliated Clinical Services.
West Bend, Wisconsin 2005
“Challenges in the Treatment of Bipolar Disorder.” Riverside Mental Health. Mequon,
Wisconsin 2005
“Challenges in the Treatment of Bipolar Disorder.” Winnebago, Mental Health Clinic.
Winnebago, Wisconsin 2005
“Challenges in the Treatment of Bipolar Disorder.” Agnesian Behavioral Health. Fon-du-lac,
Wisconsin 2005
“Challenges in the Treatment of Bipolar Disorder.” Oshkosh, Wisconsin 2005
“Challenges in the Treatment of Bipolar Disorder.” Bellin Psychiatry. Green Bay, Wisconsin 2005
“Challenges in the Treatment of Bipolar Disorder.” Riverside Psychiatry. DePere, Wisconsin 2005
“CATIE: What the Data Really Says.” Williamsburg, Virginia 2005
“Anxiety Disorders-Ask the Expert?” AstraZeneca. Wilmington, Delaware 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Syracuse, New York 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Connections.
Utica, New York 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” NYS Department of
Corrections. Utica, New York 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Utica, New York 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Binghamton Psychiatric
Center. Binghamton, New York 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Elmira Psychiatric Center.
Elmira, New York 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Dundee, New York 2005
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” Dunkirk, New York 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Wilmington Community Mental Health Center. Wilmington, Delaware 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Community Mental Health Center. Muskegon, Michigan 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Spring Lake, Michigan 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Forrest View Hospital. Grand Rapids, Michigan 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
West Michigan Community Mental Health Center. Baldwin, Michigan 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Dominion Psychiatric. Virginia Beach, Virginia 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Virginia Beach, Virginia 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Bala Cynwyd, Pennsylvania 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Gulph Mills, Pennsylvania 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Pasco, Washington 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Kennewick, Washington 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Eastern State Hospital. Spokane, Washington 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Spokane, Washington 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Grand Rounds Lecture. Harborview Medical Center. Seattle, Washington 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Seattle, Washington 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Steven’s Hospital. Edmonds, Washington 2005
“Atypical Antipsychotics and Aggression.” Southwestern Virginia Mental Health Institute.
Marion, Virginia 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Radford, Virginia 2005
“Geriatric Psychoses.” Piedmont Geriatric Hospital. Burkeville, Virginia 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Catawba State Hospital, Virginia 2005
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Roanoke, Virginia 2005
“CATIE: A Critical Review and Discussion.” Grand Rounds Lecture. Waterbury Behavioral
Hospital. Waterbury, Connecticut 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Waterbury, Connecticut, 2006
“What CATIE Does and Doesn’t Tell Us About Treating Our Patients.” Grand Rounds Lecture.
Connecticut Valley Hospital. Middletown, Connecticut 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
New Haven, Connecticut 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Dublin Mental Health Center. Dublin, Georgia 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Millidgeville, Georgia 2006
“Achieve Both Efficacy and Metabolic Health with Atypical Therapy.” River Edge Behavioral
Health Center. Macon, Georgia 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Clayton Center Behavioral Health. Jonesboro, Georgia 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Buckhead, Georgia 2006
“Seroquel (quetiapine) for the Treatment of Mania in Bipolar Disorder.” Veterans Administration
Medical Center. Perry Point, Maryland 2006
“Atypical Antipsychotics: Different Drugs, Different Risks. Grand Rounds Lecture. Carilion
Health Care. Roanoke, Virginia 2006
“Atypical Antipsychotics in Acute Aggression.” Veterans Administration Medical Center.
Roanoke, Virginia 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Bainbridge, Georgia 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Albany, Georgia 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Valdosta, Georgia 2006
“Advances in the Treatment of Schizophrenia-Results of CATIE Phase I.”
Montgomery County Emergency Services. Norristown, Pennsylvania 2006
“Advances in the Treatment of Schizophrenia-Results of CATIE Phase I.”
Penndel Mental Health Center. Penndel, Pennsylvania 2006
“Understanding the Importance of Metabolic Issues and the New FDA
ing for Atypical Antipsychotics. Savannah, Georgia 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Savannah, Georgia 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Savannah, Georgia 2006
“Clinical Insights for the Primary Care Clinician: Psychotrophic Therapy for Acute Bipolar
Disorder.” Wilmington, Delaware 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
McDuffie County Mental Health. Thomson, Georgia 2006
Serenity Behavioral Health System. Augusta, Georgia 2006
“The Agitated Elderly.” Georgia War Veterans Home. Augusta, Georgia 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Ogeechee Behavioral Health Services Count. Swainsboro, Georgia 2006
“Ziprasidone in the Treatment of Acute Bipolar Mania: Manic and Mixed Episodes.”
Serenity Behavioral Health System. Thomson, Georgia 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Athens, Georgia 2006
“Treatment Options in Bipolar Disorder.” Conroe MHMR. Conroe, Texas. 2006
Providence Mental Health Clinic. Waco, Texas 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Waco, Texas 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Killeen, Texas 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Temple, Texas 2006
“Bipolar Disorder for Primary Care Physicians.” Bear, Delaware 2006
“Quetiapine for the Treatment of Mania in Bipolar Disorder.” Lewes, Delaware 2006
“Forensic Psychiatry for Non-forensic Psychiatrists.” Grand Rounds Lecture. UMDNJ.
Camden, New Jersey 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Western Psychiatric Institute. Rochester, Pennsylvania 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Grand Rounds Lecture. Southwestern Pennsylvania Veterans Administration Hospital.
Pittsburgh, Pennsylvania 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Pittsburgh, Pennsylvania 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Jefferson Hospital. Jefferson Hills, Pennsylvania 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Springfield State Hospital. Sykesville, Maryland 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Bethesda, Maryland 2006
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for Atypical
Antipsychotics. Charlotte Community Mental Health Center. Punta Gorda, Florida 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Sarasota, Florida 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Grand Rounds Lecture. Samaritan Hospital. Troy, New York 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Saratoga Springs, New York 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Grand Rounds Lecture. Albany Medical Center. Albany, New York 2006
“CATIE, Efficacy & Metabolic Health in Patients on Atypical Antipsychotic Therapy.”
Albany, New York 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Pembroke Pines State Hospital. Pembroke Pines, Florida 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Miami, Florida 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
South County Mental Health Clinic. Delray, Florida 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Boca Raton, Florida 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Community Health Center, Miami, Florida 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Miami, Florida 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Southampton Clinic. Southampton, Pennsylvania 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
New Life Community Health Services. Philadelphia, Pennsylvania 2006
“Bipolar Disorder for Primary Care Physicians.” Wilmington, Delaware 2006
“Quetiapine for the Treatment of Mania in Bipolar Disorder.” Dover, Delaware 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Norfolk, Virginia 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Eastern State Hospital. Williamsburg, Virginia 2006
“Choosing the Optimal First-Choice Switch Agent: Achieve Antipsychotic Efficacy and Minimize
Metabolic Risk.” Comcare of Sedgwick County. Wichita, Kansas 2006
“Choosing the Optimal First-Choice Switch Agent: Achieve Antipsychotic Efficacy and Minimize
Metabolic Risk.” Wichita, Kansas 2006
“Choosing the Optimal First-Choice Switch Agent: Achieve Antipsychotic Efficacy and Minimize
Metabolic Risk.” Mental Health Clinic of Central Kansas. Salina, Kansas 2006
“Choosing the Optimal First-Choice Switch Agent: Achieve Antipsychotic Efficacy and Minimize
Metabolic Risk.” Topeka, Kansas 2006
“Biology of Aggression.” Johnson County Mental Health. Shawnee, Kansas 2006
“Choosing the Optimal First-Choice Switch Agent: Achieve Antipsychotic Efficacy and Minimize
Metabolic Risk.” Valeo Behavioral Health. Topeka, Kansas 2006
“Choosing the Optimal First-Choice Switch Agent: Achieve Antipsychotic Efficacy and Minimize
Metabolic Risk.” Kansas City, Kansas 2006
“Balancing Effectiveness and Safety in Schizophrenia: Clinical and Forensic Issues.” Florida
Psychiatric Society Annual Meeting CME Lecture. Boca Raton, Florida 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Cockeysville, Maryland 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Baltimore, Maryland 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Detroit, Michigan 2006
“Choosing the Optimal First-Choice Switch Agent: Achieve Antipsychotic Efficacy and Minimize
Metabolic Risk.” Pontiac, Michigan 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
PATH. Philadelphia, Pennsylvania 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Charlotte, North Carolina 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
JFK Treatment Center, Black Mountain, North Carolina 2006
“Biology of Aggression.” Grand Rounds Lecture. Broughton State Hospital. Marion,
North Carolina 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Asheville, North Carolina 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Balsam Center. Waynesville, North Carolina 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Grand Rounds Lecture. Veterans Affairs Medical Center. Asheville, North Carolina 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Asheville, North Carolina 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Family Services of Chemung County. Elmira, New York 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Vestal, New York 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Charleston, South Carolina 2006
“Ask the Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Western Central Georgia regional Hospital. Columbus, Georgia 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Columbus, Georgia 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Erie, Pennsylvania 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Erie, Pennsylvania 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Fairmont Behavioral Health.
Philadelphia, Pennsylvania 2006
“Ziprasidone in the Treatment of Bipolar Disorder.” Northwest Human Services.
Germantown, Pennsylvania 2006
“Challenges in the Treatment of Bipolar Disorder.” Rogers Memorial Hospital. Milwaukee,
Wisconsin 2006
“Symptom Control to Positive Patient Outcomes.” Psychiatric Services of Racine. Racine,
Wisconsin 2006
“Symptom Control to Positive Patient Outcomes.” Milwaukee, Wisconsin 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Grand Rapids, Michigan 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Pine Rest Mental Health. Grand Rapids, Michigan 2006
“The CATIE Study: Use, Misuse, and Abuse.” Annual Meeting of the American Academy of
Psychiatry and the Law. Chicago, Illinois 2006
“The CATIE Study: Use, Misuse, and Abuse.” Annual Meeting of the American Academy of
Psychiatry and the Law. Virginia Beach, Virginia 2006
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Pine Rest Mental Health. Pittsburgh, Pennsylvania 2006
“Forensic Psychiatry for the Non-Forensic Psychiatrist.” Washington Hospital-New Directions
in Psychiatry. Southpointe, Pennsylvania 2006
“Primary Education in Bipolar Disorder.” Dallas, Texas 2006
“Unipolar Depression is a Diagnosis of Exclusion: Recognizing Bipolar Disorder in Primary
Care.” Wilmington, Delaware 2006
“Ask the Expert: Geriatric Psychiatry.” Jewish Family Services. Wilmington, Delaware 2006
“Surviving the Holidaze-Your Guide to Coping with Year End Stress.” Wilmington, Delaware 2006
“Ziprasidone in Acute Mania and Mixed States.” Birmingham, Alabama 2007
“Ziprasidone in Acute Mania and Mixed States.” Birmingham, Alabama 2007
“Ziprasidone in Acute Mania and Mixed States.” Grand Rounds Lecture. Bryce Hospital.
Tuscaloosa, Alabama 2007
“Ziprasidone in Acute Mania and Mixed States.” Montgomery Mental Health Clinic.
Montgomery, Alabama 2007
“Ziprasidone in Acute Mania and Mixed States.” Montgomery, Alabama 2007
“Ziprasidone in Acute Mania and Mixed States.” Baypointe Hospital. Mobile, Alabama 2007
“Ziprasidone in Acute Mania and Mixed States.” Searcy Hospital. Mount Vernon,
Alabama 2007
“Ziprasidone in Acute Mania and Mixed States.” Horsham Clinic. Ambler, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Central Montgomery Mental Health Clinic.
Norristown, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” King of Prussia, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” APS. Virginia Beach, Virginia 2007
“Ziprasidone in Acute Mania and Mixed States.” Virginia Beach, Virginia 2007
“Ziprasidone in Acute Mania and Mixed States.” Lebanon Veterans Administration
Medical Center. Lebanon, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Leola, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Harrisburg, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Philhaven Hospital. Mt. Gretna, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Harrisburg, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Clarendon County Mental Health, Manning,
South Carolina 2007
“Ziprasidone in Acute Mania and Mixed States.” Charleston, South Carolina 2007
“Ziprasidone in Acute Mania and Mixed States.” Medical University of South Carolina.
Charleston, South Carolina 2007
“Ziprasidone in Acute Mania and Mixed States.” Charleston, South Carolina 2007
“Ziprasidone in Acute Mania and Mixed States.” Warren Smith Mental Health Center.
Philadelphia, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Philadelphia, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Union Clinic. Bronx, New York 2007
“Ziprasidone in Acute Mania and Mixed States.” Grand Rounds Lecture. Bronx Psychiatric
Center. Bronx, New York 2007
“Ziprasidone in Acute Mania and Mixed States.” Mamaroneck, New York 2007
“Ziprasidone in Acute Mania and Mixed States.” Keypoint Medical. Aberdeen, Maryland 2007
“Ziprasidone in Acute Mania and Mixed States.” Upper Bay Counseling. Havre de Grace,
Maryland 2007
“Ziprasidone in Acute Mania and Mixed States.” Havre de Grace, Maryland 2007
“Bipolar Disorder in Primary Care.” Wilmington Hospital. Wilmington, Delaware 2007
“Ziprasidone in Acute Mania and Mixed States.” Athens, Georgia 2007
“Ziprasidone in Acute Mania and Mixed States.” Augusta, Georgia 2007
“Ziprasidone in Acute Mania and Mixed States.” Ogeechee Behavioral Health Services,
Waynesboro, Georgia 2007
Efficacy, Tolerability, and Safety of Atypical Antipsychotics: What Does Science Tell Us?
Medical College of Georgia. Augusta, Georgia 2007
“Ziprasidone in Acute Mania and Mixed States.” St. Alban’s Behavioral Health Services,
Christiansburg, Virginia 2007
“Ziprasidone in Acute Mania and Mixed States.” Roanoke, Virginia 2007
“Ziprasidone in Acute Mania and Mixed States.” Lewis Gale Pavilion. Salem, Virginia 2007
“Ziprasidone in Acute Mania and Mixed States.” Lebanon, Virginia 2007
“Understanding the Importance of Metabolic Issues and the New FDA Labeling for
Atypical Antipsychotics.” Bryn Mawr, Pennsylvania 2007
“Atypical Antipsychotics in Bipolar Disorder.” Wilmington, Delaware 2007
“Ziprasidone in Acute Mania and Mixed States.” Veterans Affairs Medical Center.
Tampa, Florida 2007
“Ziprasidone in Acute Mania and Mixed States.” Tampa, Florida 2007
“Ziprasidone in Acute Mania and Mixed States.” Ruth Cooper Community Mental Health
Center, Ft. Myers, Florida 2007
“Ziprasidone in Acute Mania and Mixed States.” Ft. Myers, Florida 2007
“Ziprasidone in Acute Mania and Mixed States.” Tampa, Florida 2007
“Ziprasidone in Acute Mania and Mixed States.” Ft. Lauderdale, Florida 2007
“Ziprasidone in Acute Mania and Mixed States.” South County Mental Health Center,
Delray, Florida 2007
“The Brain vs. The Mind: Aeronautical Decision Making Under Stress.” Horizon Helicopters.
Newark, Delaware 2007
“Ziprasidone in Acute Mania and Mixed States.” Wedge Medical Center, Philadelphia,
Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Community Council Mental Health Center,
Philadelphia, Pennsylvania 2007
“Ziprasidone in Acute Mania and Mixed States.” Philadelphia, Pennsylvania 2007
“CATIE 1 & 2: the Dilemma of Effectiveness in the Treatment of People with Schizophrenia”
Sharpe State Hospital. Weston, West Virginia 2007
“Ziprasidone in Acute Mania and Mixed States.” Morgantown, West Virginia 2007
“Using Atypical Antipsychotics when Treating Acute Mania and Mixed Episodes: Metabolic
Considerations.” Charleston Area Medical Center. Charleston, West Virginia 2007
“Atypical Antipsychotics for Acute Bipolar Manic and Mixed Episodes.” Thomas Memorial
Hospital. Charleston, West Virginia 2007
“Ziprasidone in Acute Mania and Mixed States.” Potomac Ridge Behavioral Health.
Rockville, Maryland 2007
“Ziprasidone in Acute Mania and Mixed States.” Bethesda, Maryland 2007
“Ziprasidone in Acute Mania and Mixed States.” Binghamton Health Center. Binghamton,
New York 2007
“Ziprasidone in Acute Mania and Mixed States.” Vestal, New York 2007
“Ziprasidone in Acute Mania and Mixed States.” Saratoga Hospital. Saratoga Springs,
New York 2007
“Ziprasidone in Acute Mania and Mixed States.” Samaritan Hospital. Troy, New York 2007
“Ziprasidone in Acute Mania and Mixed States.” Albany, New York 2007
“Treat to Achieve Results with Geodon: Efficacy and Tolerability. Baltimore Behavioral
Health. Baltimore, Maryland 2007
“Treat to Achieve Results with Geodon: Efficacy and Tolerability. University of Maryland
Psychiatric Urgent Care Center. Baltimore, Maryland 2007
“Treat to Achieve Results with Geodon: Efficacy and Tolerability. Baltimore, Maryland 2007
“Ziprasidone in Acute Mania and Mixed States.” Friends Hospital. Philadelphia, Pennsylvania 2007
“Quetiapine in the Treatment of Schizophrenia.” Wilmington, Delaware 2007
“Ziprasidone in Acute Mania and Mixed States.” Human Services. Downingtown, Pennsylvania 2007
“Primary Care Series: New Insights in the Treatment of Bipolar Depression.” Newark, Delware 2007
“Ask the Brain Injury Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2007
“Psychiatric Diagnosis of Fibromyalgia: A Hands-off Approach.” Wilmington, Delaware 2007
“Psychiatric Diagnosis of Fibromyalgia: A Hands-off Approach.” Neurology Grand Rounds.
St. Francis Hospital. Wilmington, Delaware 2007
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.” Lebanon
VA Medical Center Hospital. Lebanon, Pennsylvania 2007
“Traumatic Brain Injury: What Happens After Acute Rehabilitation?” Keynote Speaker-Brain
Injury Association of Delaware Annual Conference. Dover, Delaware 2007
“Surviving the Holidaze.” Wilmington, Delaware 2007
“Diagnosis and Management of Fibromyalgia.” Santa Monica, California 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Santa Monica, California 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Long Beach, California 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Long Beach, California 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Northern Nevada Mental Health Services. Reno, Nevada 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Reno, Nevada 2008
“Diagnosis and Management of Fibromyalgia.” Wilmington, Delaware 2008
“Diagnosis and Management of Fibromyalgia.” Towson, Maryland 2008
“Diagnosis and Management of Fibromyalgia.” Towson, Maryland 2008
“Diagnosis and Management of Fibromyalgia.” Baltimore, Maryland 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Tropical Health. Edinburg, Texas 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Tropical Health. McAllen, Texas 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Tropical Health. San Antonio, Texas 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
San Antonio, Texas 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Penndel Mental Health, Penndel, Pennsylvania 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Radnor, Pennsylvania 2008
“Primum Non Noncere-First Do No Harm-Safety in the Treatment of Schizophrenia and
Bipolar Disorder.” Birmingham, Alabama 2008
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic and Mixed Episodes.” Tuscaloosa Psychiatric Society, Tuscaloosa, Alabama 2008
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic and Mixed Episodes.” Atlanta, Georgia 2008
“Rapid Control of Symptoms and Improved Outcomes in Patients with Acute Bipolar
Manic and Mixed Episodes.” Alpharetta, Georgia 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Central Valley Hospital. Middletown, Connecticut 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Lyme, Connecticut 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Waterbury, Connecticut 2008
“Forensic Psychiatry for the Non-Forensic Psychiatrist.” Grand Rounds Lecture. Waterbury
Hospital. Waterbury, Connecticut 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Westport, Connecticut 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Stamford, Connecticut 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Catawba State Hospital. Catawba, Virginia 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Roanoke, Virginia 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Washington Hospital. Washington, Pennsylvania 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Waynesburg, Pennsylvania 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Pittsburgh, Pennsylvania 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Baltimore Behavioral Health. Baltimore, Maryland 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Baltimore, Maryland 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Mobile, Alabama 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Bay Pointe Hospital. Mobile, Alabama 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Baldwin Mental Health. Fairhope, Alabama 2008
“Psychiatric Diagnosis of Fibromyalgia: A Hands-off Approach.” Sheppard Pratt
Hospital. Towson, Maryland 2008
“Psychiatric Diagnosis of Fibromyalgia: A Hands-off Approach.” Towson, Maryland 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Springfield State Hospital. Sykesville, Maryland 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Springfield State Hospital. Bethesda, Maryland 2008
“Psychiatric Diagnosis of Fibromyalgia: A Hands-off Approach.” State College,
Pennsylvania 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Springfield State Hospital. Altoona, Pennsylvania 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Westchester Medical Center. Valhalla, New York 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Springfield State Hospital. Chappaqua, New York 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Arizona State Hospital.
Phoenix, Arizona 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes”. Phoenix, Arizona 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Phoenix, Arizona 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Southwest Behavioral
Health. Phoenix, Arizona 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Phoenix, Arizona 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” SM Mental Health
Clinic. Apache Junction, Arizona 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Scottsdale, Arizona 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Delaware County
Community Mental Health Clinic. Walton, New York 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Vestal, New York 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Tompkins Community
Mental Health Clinic. Ithaca, New York. 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Elmira, New York 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Community Services.
Lancaster, Pennsylvania 2008
“Going Beyond Positive Symptoms to Positive Patient Outcomes.” Kimberton, Pennsylvania 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Kingsboro Psychiatric Center, Brooklyn, New York 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Coney Island Hospital, New York, New York 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
Brookdale Hospital, Brooklyn, New York 2008
“Achieve Both Efficacy and Metabolic Health with Atypical Antipsychotic Therapy.”
New York, New York 2008
The Latest Advances in the Diagnosis and Treatment of Bipolar disorder and SADS. New
Directions Delaware. Wilmington, Delaware 2008
“Overview of Geodon for the Treatment of Schizophrenia.” Pittsford, New York 2008
“Seroquel for Depressive Symptoms of Bipolar Disorder.” Connections, CSP.
Wilmington, Delaware 2008
“Treating Bipolar Manic and Mixed Episodes: Assessing Both Efficacy and Tolerability
Considerations.” Friends Hospital Teleconference. Philadelphia, Pennsylvania 2008
“Treating Bipolar Manic and Mixed Episodes: Assessing Both Efficacy and Tolerability
Considerations.” Friends Hospital Teleconference. Little Falls, New Jersey 2009
“Treating Bipolar Manic and Mixed Episodes: Assessing Both Efficacy and Tolerability
Considerations.” Clifford T. Perkins Hospital. Jessup, Maryland 2009
“Treating Bipolar Manic and Mixed Episodes: Assessing Both Efficacy and Tolerability
Considerations.” Bowie, Maryland 2009
“Seroquel for Depressive Symptoms of Bipolar Disorder.” PSI. Dover, Delaware 2009
“Treating Bipolar Manic and Mixed Episodes: Assessing Both Efficacy and Tolerability
Considerations.” Path Community Mental Health. Philadelphia, Pennsylvania 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Charleston Mental Health. Charleston, South Carolina 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Charleston, South Carolina 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Medical University of South Carolina. Charleston, South Carolina 2009
“Lyrica in Fibromyalgia.” Georgetown, South Carolina. 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Medical University of South Carolina. Myrtle Beach, South Carolina 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
DRENK Mental Health. Mt. Holly, New Jersey 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Cherry Hill, New Jersey 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Towson, Maryland 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Baltimore, Maryland 2009
“Morsels for the Mind: Psychiatric Tidbits for the Hungry Primary Care Physician. American
College of Physicians Annual Meeting. Newark, Delaware 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Ft. Myers Community Mental Health. Ft. Myers, Florida 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Sarasota, Florida 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
St. Clare’s Hospital. Boonton, New Jersey 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Paramus, New Jersey 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Mountainside Hospital. East Orange, New Jersey 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Trinitas Hospital. Elizabeth, New Jersey 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Montclair, New Jersey 2009
“Overview of Ziprasidone in the Inpatient Setting.” Connecticut Valley Hospital.
Middletown, Connecticut 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.”
Old Saybrook, Connecticut 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Roanoke, Virginia 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Carillon St. Albans Hospital. Radford, Virginia 2009
“Treating Bipolar Manic and Mixed Episodes: Assessing Both Efficacy and Tolerability
Considerations.” Phoenix, Arizona 2009
“Considering Treatment Goals in the Management of Bipolar Manic and Mixed Episodes.
Phoenix, Arizona 2009
“CASES Presentation-Outpatient Schizophrenia.” Egg Harbor City, New Jersey 2009
“CASES Presentation-Outpatient Bipolar Disorder.” Andrews Air Force Base, Clinton, Maryland 2009
“CASES Presentation-Outpatient Bipolar Disorder.” Prince Frederick, Maryland 2009
“CASES Presentation-Inpatient Schizophrenia.” Central State Hospital. Milledgeville,
Georgia 2009
“CASES Presentation-Outpatient Schizophrenia.” River Edge Community Mental Health
Center. Macon, Georgia 2009
“CASES Presentation-Outpatient Bipolar Disorder.” Atlanta, Georgia 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Serenity Mental Health. Augusta, Georgia 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Lexington Community Mental Health. Lexington, South Carolina 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Lancaster Community Mental Health. Lansing, Michigan 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Flint, Michigan 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. TTI. Oxford, Michigan 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Birmingham, Michigan 2009
“The Management of Fibromyalgia.” West Bloomfield, Michigan 2009
“The Management of Fibromyalgia.” Troy, Michigan 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Elmira, New York 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Buffalo, New York 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Community General Hospital. Syracuse, New York 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Syracuse, New York 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Humanim Mental Health. Columbia, Maryland 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Chevy Chase, Maryland 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Baltimore Behavioral Health. Baltimore, Maryland 2009
“CASES Presentation-Outpatient Bipolar Disorder.” Baltimore, Maryland 2009
“Overview of Geodon in the Inpatient Setting.” Memorial Hospital. Savannah, Georgia 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Wellspan Behavioral Health. York, Pennsylvania 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. East Petersburg, Pennsylvania 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Union Memorial Hospital. Elkton, Maryland 2009
“CASES Presentation-Inpatient Bipolar Disorder.” Shepperd Pratt. Towson, Maryland 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Baltimore, Maryland 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Holy Spirit Hospital. Camp Hill, Pennsylvania 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Pottsville, Pennsylvania 2009
“Ask the Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2009
“CASES Presentation-Inpatient Bipolar Disorder.” Rockford Center. Wilmington, Delaware 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Cedar Rapids, Iowa 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Dubuque, Iowa 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Waterloo, Iowa 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Pottsville, Pennsylvania 2009
“Forensic Psychiatry: An Overview.” Grand Rounds Lecture. UMDNJ, Cooper Hospital.
Camden, New Jersey 2009
“Overview of Geodon for the Treatment of Bipolar Mixed/Manic Episodes.” Easton,
Pennsylvania 2009
“Overview of Geodon for the Treatment of Bipolar Mixed/Manic Episodes.” Shrewsbury,
New Jersey 2009
“Overview of Geodon for the Treatment of Bipolar Mixed/Manic Episodes.” Red Bank,
New Jersey 2009
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Ogeechee Behavioral Health. Waynesboro, Georgia 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Advantage Mental Health. Athens, Georgia 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Columbia, South Carolina 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Columbia Care Center. Columbia, South Carolina 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Serenity Behavioral Health. Augusta, Georgia 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Wichita, Kansas 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. The Gilbert Clinic. Bethany, Oklahoma 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Oklahoma City, Oklahoma 2010
“Overview of Geodon in the Inpatient Setting.” Hamilton Medical Center. Dalton, Georgia 2010
“Fibromyalgia: A Chronic Widespread Neurologic Pain Condition.” Georgia Pain Management.
Gainesville, Georgia 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Gainesville, Georgia 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Phoenix Center. Warner
Robbins, Georgia 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Atlanta, Georgia 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Integrated Behavioral Health. Savannah, Georgia 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Integrated Behavioral Health. Clark Center, Savannah, Georgia 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Savannah, Georgia 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Dorchester CMHC, Summerville,
South Carolina 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Charleston, South Carolina 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Waccamaw CMHC, Georgetown,
South Carolina 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Myrtle Beach, South Carolina 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Long Branch at Monmouth Medical Center. Long Branch, New Jersey 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Freehold, New Jersey 2010
“Considerations for the Continuum of Care: Treatment of Schizophrenia and Bipolar Manic
and Mixed Episodes. Healthcare Commons. Carneys Point, New Jersey 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Avalon, New Jersey 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” St. Clare’s Behavior Health.
Denville, New Jersey 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Edgewater, New Jersey 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” St. Clair Hospital. Pittsburgh,
Pennsylvania 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Pittsburgh, Pennsylvania 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” People’s Clinic. Baltimore, Maryland 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Baltimore, Maryland 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” San Bernardino, California 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Palm Desert, California 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” San Diego , California 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” San Diego, California 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Midvale, Utah 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Boise, Idaho 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Las Vegas, Nevada 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Las Vegas, Nevada 2010
“Mild Traumatic Brain Injury and Post Traumatic Stress Disorder: Why the Confusion?”
Medical Society of Delaware Annual Meeting. Newark, Delaware 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Cedar Rapids, Iowa 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” West Burlington, Iowa 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Peoria, Illinois 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” H. Douglas Singer Mental Health
Center. Rockford, Illinois 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Franklin Square Hospital.
Rosedale, Maryland 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Glyndon, Maryland 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Macungie, Pennsylvania 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Peninsula Regional Medical Center.
Salisbury, Maryland 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Syracuse, New York 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Victor, New York 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Amherst, New York 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Fayetteville, New York 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Cumberland, Maryland 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Morgantown, West Virginia 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Keypoint Health Services,
Baltimore, Maryland 2010
“Geodon Maintenance Treatment in Bipolar Disorder.” Baltimore, Maryland 2010
“CASES-Bipolar Maintenance.” Arapahoe Douglas Mental Health Center. Littleton, Colorado 2010
“CASES-Bipolar Maintenance.” Denver, Colorado 2010
“CASES-An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” Utah State Hospital. Provo, Utah 2010
“CASES-Bipolar Maintenance.” Salt Lake City, Utah 2010
“CASES-Bipolar Maintenance.” Blue Ridge Behavioral Health. Roanoke, Virginia 2010
“CASES-Bipolar Maintenance.” Bluefield, Virginia 2010
“CASES-Bipolar Maintenance.” Friends Hospital. Philadelphia, Pennsylvania 2010
“CASES-Bipolar Maintenance.” Gaithersburg, Maryland 2010
“CASES-Bipolar Maintenance.” Chevy Chase, Maryland 2010
“Wind Energy for a Small Community-The Tangier Island, Virginia Experience.” Virginia
Wind Energy Conference. Harrisonburg, Virginia 2010
“CASES-Bipolar Maintenance.” Baltimore, Maryland 2010
“CASES-Bipolar Maintenance.” Baltimore, Maryland 2010
“CASES-Bipolar Maintenance.” Salisbury, Maryland 2010
“CASES-Bipolar Maintenance.” Millennium Psychiatry. St. Louis, Missouri 2010
“CASES-Bipolar Maintenance.” St. Alexius Hospital. St. Louis, Missouri 2010
“CASES-Bipolar Maintenance.” St. Louis, Missouri 2010
“Learning in Practice: A Case Study to Illustrate the Science and Clinical Issues of
Schizophrenia. WebEx Conference 2010
“Schizophrenia: Building Awareness-Advancing Understanding.” Kansas City, Missouri 2010
“CASES-Bipolar Maintenance.” Detroit, Michigan 2010
“Neuropsychiatric Complications of Stroke. 10th Annual Delaware Stroke Initiative Conference.
Newark, Delaware 2010
“Schizophrenia: Building Awareness-Advancing Understanding.” Troy, Michigan 2010
“Schizophrenia: Building Awareness-Advancing Understanding.” Dayton, Ohio 2010
“Practice Guidelines: Where Do They Belong?” American Academy of Psychiatry and the
Law Annual Meeting. Tucson, Arizona 2010
“Learning in Practice. A Case Study to Illustrate the Science and Clinical Issues of
Schizophrenia.” Providence, Rhode Island 2010
“Learning in Practice. A Case Study to Illustrate the Science and Clinical Issues of
Schizophrenia.” Washington, DC 2010
“Meet Beth: An Interactive Case Discussion on Acute Management of an Inpatient with
Bipolar I Disorder. Friends Hospital. Philadelphia, Pennsylvania 2011
“Meet Beth: An Interactive Case Discussion on Acute Management of an Inpatient with
Bipolar I Disorder. Horsham Clinic. Ambler, Pennsylvania 2011
“Meet Beth: An Interactive Case Discussion on Acute Management of an Inpatient with
Bipolar I Disorder. Blue Belle, Pennsylvania 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” Baltimore Washington Medical Center. Glen Burnie, Maryland 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Columbia, Maryland 2011
“Meet Beth: An Interactive Case Discussion on Acute Management of an Inpatient with
Bipolar I Disorder. Raritan Bay Medical Center. Perth Amboy, New Jersey 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Red Bank, New Jersey 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” Friendship Community Mental Health Center. Phoenix, Arizona 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Phoenix, Arizona 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” New Arizona Family Institute. Mesa, Arizona 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Paradise Valley, Arizona 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” Arapahoe Mental Health. Littleton, Colorado 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Greenwood Village, Colorado 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” Spanish Peaks Mental Health. Pueblo, Colorado 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Front Range Psychiatric. Pueblo, Colorado 2011
“Meet Christine: An Interactive Case Discussion on Maintenance Treatment of Bipolar I
Disorder.” Colorado Springs, Colorado 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” North Range Behavioral Health. Greeley, Colorado 2011
“Meet Christine: An Interactive Case Discussion on Maintenance Treatment of Bipolar I
Disorder.” Human Services. Downingtown, Pennsylvania 2011
“Meet Beth: An Interactive Case Discussion on Acute Management of an Inpatient with
Bipolar I Disorder.” McKay Dee Behavioral Health. Ogden, Utah 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Salt Lake City, Utah 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Terry Reilly Behavioral Health. Namba, Idaho 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Boise, Idaho 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Renew Counseling Center. Milwaukee, Wisconsin 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Brookfield, Wisconsin 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Fond du Lac, Wisconsin 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Green Bay, Wisconsin 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Stoughton Family Counseling. Stoughton, Wisconsin 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Madison, Wisconsin 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
DeKalb, Illinois 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Rockford, Illinois 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Lower Shore Clinic. Salisbury, Maryland 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Salisbury, Maryland 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
St. Augustine, Florida 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
St. Johns County Mental Health. Jacksonville, Florida 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. San Antonio, Texas 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. San Antonio, Texas 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Texas State School. Corpus Christi, Texas 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Corpus Christi, Texas 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Edinburgh, Texas 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
South Texas Behavioral Health. Edinburgh, Texas 2011
“A New Atypical Antipsychotic Agent for the Treatment of Schizophrenia.” Hockessin, Delaware 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
MUSC. Charleston, South Carolina 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment. Charleston, South Carolina 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Clarendon Mental Health Clinic. Manning, South Carolina 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Columbia Mental Health Center. Columbia, South Carolina 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” Arlington, Virginia 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” El Paso, Texas 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Columbia Mental Health Center. El Paso, Texas 2011
“Meet Christine: An Interactive Case Discussion on Maintenance Treatment of Bipolar I
Disorder. Alternatives Behavioral Center. El Paso, Texas 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” Douglas County Mental Health. Omaha, Nebraska 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Omaha, Nebraska 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” Lincoln Regional Center. Lincoln, Nebraska 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Lincoln, Nebraska 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Greenville Mental Health. Greenville, South Carolina 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Greenville, South Carolina 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” Columbia Area Mental Health. Columbia, South Carolina 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” Columbia Care. Columbia, South Carolina 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Peoples Place. Milford, Delaware 2011
“A New Atypical Antipsychotic Agent for the Treatment of Schizophrenia.” Fruitland, Maryland 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” Alexandria, Virginia 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Upper Chesapeake Bay Counseling. Havre de Grace, Maryland 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Baltimore, Maryland 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” Huntsville Hospital. Huntsville, Alabama 2011
“Case Review of a 44-Year Old Male with Bipolar I Disorder Experiencing Sedation”
Huntsville, Alabama 2011
“Meet Jim: An Interactive Case Discussion on Acute Management of an Outpatient with
Schizophrenia.” Mobile Mental Health. Mobile, Alabama 2011
“Meet Kate: An Interactive Case Discussion on Acute Management of an Outpatient with
Bipolar I Disorder.” Mobile, Alabama 2011
“Meet Adam: An Interactive Case Discussion on Acute Management of an Inpatient with
Schizophrenia.” BayPointe Hospital. Mobile, Alabama 2011
“Clinical Management of Major Depressive Disorder: A Patient Case Approach.” Alabama
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment.” Community Service Board. Arlington, Virginia 2011
“Case Review of a 29-Year Old Female with Bipolar I Disorder and Dissatisfied with Current
Treatment.” Millcreek Community Hospital. Erie, Pennsylvania 2011
“Meet Larry: An Interactive Case Discussion on Maintenance Treatment of Bipolar I Disorder.
Pittsburgh, Pennsylvania 2011
“EmSam-an effective and unique transdermal choice for treatment of major depressive disorder.
Columbia, South Carolina 2011
“Ask the Expert: Everything You Want to Know About Brain Injury.” Brain Injury Association of
Delaware. Wilmington, Delaware 2001
“A New Atypical Antipsychotic Agent for the Treatment of Schizophrenia.” Dover, Delaware 2011
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Eastern Shore Psychiatric Services. Easton, Maryland 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Pittsburgh, Pennsylvania 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Pittsburgh, Pennsylvania 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Pikesville, Maryland 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Cockeysville, Maryland 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Veterans Association Medical Center. Altoona, Pennsylvania 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Altoona, Pennsylvania 2011
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Lewes, Delaware 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Richmond, Virginia 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Fredericksburg, Virginia 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Cleveland, Ohio 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Charak Center for Health and Wellness. Medina, Ohio 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Cleveland, Ohio 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” State College, Pennsylvania 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” DuBois, Pennsylvania 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” College Park, Maryland 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Bethesda, Maryland 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” DuBois Regional Medical Center. DuBois, Pennsylvania 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Bradford, Pennsylvania 2011
“EmSam: An Effective and Unique Transdermal Choice for the Treatment of Major Depression;
Roundtable Program.” Meadville, Pennsylvania 2011
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Kent County Behavioral Health. Dover, Delaware 2011
“Challenges and Opportunities in Schizophrenia Treatment: The Community Mental Health
Perspective. Community Service Board. Petersburg, Virginia 2011
“Lurasidone in the treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and
Olanzapine-Controlled Study.” Williamsburg, Virginia 2011
“Lurasidone in the treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and
Olanzapine-Controlled Study.” Virginia Beach, Virginia 2011
“Lurasidone in the treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and
Olanzapine-Controlled Study.” Rehoboth Beach, Delaware 2011
“Challenges and Opportunities in Schizophrenia Treatment: The Community Mental Health
Perspective. Peoples Place. Milford, Delaware 2011
“Challenges and Opportunities in Schizophrenia Treatment: The Community Mental Health
Perspective. Peoples Place. Dover, Delaware 2011
“Pandora’s Box: Black Box Warnings.” Annual Meeting of the American Academy of
Psychiatry and the Law. Boston, Massachusetts 2011
“EmSam-The First and Only Transdermal Choice for the Treatment of Major Depressive
Disorder.” Global Psychiatric Congress. Neuroscience Educational Institute.
Colorado Springs, Colorado 2011
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Wilmington, Delaware 2012
“New Theories: Schizophrenia as Neurodevelopmental Disorder.” Psychiatric Society of
Delaware. New Castle, Delaware 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
King of Prussia, Pennsylvania 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Bala Cynwyd, Pennsylvania 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Wilmington Delaware 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Horsham Clinic. Ambler, Pennsylvania 2012
“EmSam-The First and Only Transdermal Choice for the Treatment of Major Depressive
Disorder.” Annual Meeting of the American Academy of Clinical Psychiatrists.
Chicago, Illinois 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Ellendale, Delaware 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
JFK Behavioral Health. Philadelphia, Pennsylvania 2012
“Lurasidone in the treatment of Schizophrenia: A Randomized, Double-Blind, Placebo-
and Olanzapine Controlled Study.” Blue Bell, Pennsylvania 2012
“Ask the Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Kent and Sussex Behavioral Health. Dover, Delaware 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
NHS Delaware County. Sharon Hill, Pennsylvania 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Wedge Medical. Philadelphia, Pennsylvania 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Kirkbride Center. Philadelphia, Pennsylvania 2012
“Opportunities in the treatment of Schizophrenia: Review of an Atypical Antipsychotic Agent.”
Community Council for Mental Health. Philadelphia, Pennsylvania 2012
“Legal, Ethical, and Risk Implications of Psychotropic Treatment in the
Pregnancy/Perinatal Period.” Annual Meeting of the American Academy of Psychiatry
and the Law. Montreal, Canada 2012
“Challenges and Opportunities in Schizophrenia Treatment: An Update for the Inpatient
Psychiatry Team. Pottstown Memorial Medical Center. Pottstown, Pennsylvania 2012
“Challenges and Opportunities in Schizophrenia Treatment: An Update for the Inpatient
Psychiatry Team. Reading, Pennsylvania 2012
“Challenges and Opportunities in Schizophrenia Treatment: An Update for the Inpatient
Psychiatry Team. Lower Bucks Hospital. Bristol, Pennsylvania 2012
“Lurasidone in the Treatment of Adult Patients with Schizophrenia.” Horizon House.
Newark, Delaware 2012
“Lurasidone in the Treatment of Adult Patients with Schizophrenia.” Crozer-Chester
Hospital. Chester, Pennsylvania. 2012
“Lurasidone in the Treatment of Adult Patients with Schizophrenia.” Northeast
Community Center for Behavioral Health. Philadelphia, Pennsylvania 2013
“Lurasidone in the Treatment of Adult Patients with Schizophrenia.” Delmarva
Behavioral Health. Centreville, Maryland 2013
“Ask the Expert.” Brain Injury Association of Delaware. Dover, Delaware 2013
“Treatment Considerations for Adult Patients with Schizophrenia in the Institution.
Friends Hospital. Philadelphia, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Charleston, South Carolina 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Clarendon County Mental Health Center. Manning, South Carolina 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Berkeley County Mental Health Center. Moncks Corner, South Carolina 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” King of Prussia, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Wilmington, Delaware 2013
“Rational Psychopharmacology in the Treatment of Traumatic Brain Injury.” Brain Injury
Association of Delaware Annual Meeting. Wilmington, Delaware 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Haven Behavioral Health. Reading, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Reading, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Threshold Rehab Services. Reading, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Fellowship Health Resources. Phoenixville, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Yardley, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Philadelphia, Pennsylvania 2013
“Treatment Considerations for Adult Patients with Schizophrenia in the Institution.
St. Luke’s Hospital. Quakertown, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Millville, New Jersey 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Philadelphia, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Philadelphia, Pennsylvania 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Atlantic City, New Jersey 2013
“Ask the Expert.” Brain Injury Association of Delaware. Wilmington, Delaware 2013
“What is She Talking About? Is my Patient Psychotic?” University of Delaware Counseling
Center. Newark, Delaware 2013
“Treatment Considerations for Adult Patients with Schizophrenia in the Institution.
Friends Hospital. Mildred Mitchell – Bateman Hospital. Huntington, West Virginia 2013
“Opportunities in the Treatment of Schizophrenia: Review of an Atypical Antipsychotic
Agent.” Charleston, West Virginia 2013
“Treatment Considerations for Adult Patients with Schizophrenia in the Institution.
Friends Hospital. White Sulphur Springs, West Virginia 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Newark, Delaware 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Philadelphia, Pennsylvania 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Millville, New Jersey 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Doylestown, Pennsylvania 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Bryn Mawr, Pennsylvania 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Newpoint Behavioral Health. Sewell, New Jersey 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Doylestown, Pennsylvania 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” National Harbor, Maryland 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Connections. Newark, Delaware 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Hockessin, Delaware 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment.” Filipino Medical Society.
Philadelphia, Pennsylvania 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Family Service Associates. Langhorne, Pennsylvania 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Horizon House. Wilmington, Delaware 2013
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Inpatient Psychiatric
Setting.” Reading Health System. Reading, Pennsylvania 2013
Bipolar Depression: Presentation, Diagnosis, and Treatment. Resources for Human
Development. Wilmington, Delaware 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Inpatient Psychiatric
Setting.” Frederick Memorial Hospital. Frederick, Maryland 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Inpatient Psychiatric
Setting.” National Harbor, Maryland 2014
“When Your Patient Commits Suicide.” Delaware State Hospital. New Castle Delaware 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Inpatient Psychiatric
Setting.” Arlington Virginia Hospital Center. Arlington, Virginia 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Inpatient Psychiatric
Setting.” Mildred Mitchell-Bateman Hospital. Huntington, West Virginia 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Charleston, West Virginia 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Inpatient Psychiatric
Setting.” Lower Bucks Hospital. Bristol, Pennsylvania 2014
“Ask the Expert on Brain Injury.” Point of Hope. Smyrna, Delaware 2014
“30 Years of Psychiatry-A Retrospective.” Organization of Physicians for the Exchange of
Knowledge (OPEK). Wilmington, Delaware 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Connections. Newark, Delaware 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Connections. Millville, New Jersey 2014
“Ask the Expert on Brain Injury.” Brain Injury Association of Delaware. Wilmington, Delaware 2014
“PTSD.” Widener University School of Law 2014
“Bipolar Depression: Presentation, Diagnosis, and Treatment in the Outpatient Psychiatry
Practice Setting.” Horizon House. Newark, Delaware 2015
“Addressing Insomnia: Focus on the Sleep-Wake System.” Woodlands, Texas 2015
“Addressing Insomnia: Focus on the Sleep-Wake System.” Frederick, Maryland 2015
“Trauma Sensitive Interviewing, VA Assessments and PTSD.” Widener School of Law,
Wilmington, Delaware 2015
“Managing the Illogical Claimant.” New Jersey Insurance Special Investigators Annual Meeting
Atlantic City, New Jersey 2015
“Just Like on TV.” American Academy of Psychiatry and the Law Annual Meeting. Ft.
Lauderdale, Florida 2015
“Managing the Illogical Claimant.” Pennsylvania Insurance Special Investigators Annual
Meeting. Hershey, Pennsylvania 2016
“Ask the Expert on Brain Injury.” Kent Sussex Industries. Milford, Delaware 2017
“The Aging Mind: Mental Health and Alzheimer’s in the Community.” Dover, Delaware 2017
“Intended and Unintended Consequences of HB 302, the Delaware Mental Health Gun Bill”
Delaware Psychological Association. Wilmington, Delaware 2019
“Teleforensics: Standard of Care and Malpractice in Telepsychiatry.” Annual Meeting of the
American Academy of Psychiatry and the Law. Baltimore, Maryland 2019
“Protecting the Public: What the Delaware Gun Law HB 302 Requires of Physicians.” Medical
Society of Delaware. Newark, Delaware 2019
“Seeing Through the Mask: COVID & Mental Health.” Delaware Coalition of Nurse
Practitioners. Zoom CME presentation. 2022